OBO_ID (LABEL):	CHEBI_27563 (arsenic atom)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2022678	10/2007	S0-PMC2022678	['determinants of Arsenic Metabolism: Blood Arsenic metabolites, Plasma Folate, Cobalamin, and Homocysteine concentrations in maternal–newborn pairs\n\nabstract\n\nbackground\nin bangladesh, tens of millions of People have been Consuming waterborne Arsenic for decades.']	N/A	N/A	[('CHEBI_85195', '9,10-epoxyoctadecanoate', 16, 'Arsenic'), ('GO_0018871', '1-aminocyclopropane-1-carboxylate metabolic process', 16, 'Arsenic Metabolism'), ('UBERON_0000178', 'blood', 36, 'Blood'), ('CHEBI_85195', '9,10-epoxyoctadecanoate', 42, 'Arsenic'), ('UBERON_0001969', 'blood plasma', 63, 'Plasma'), ('CHEBI_81245', 'Vulpecholate', 70, 'Folate'), ('CHEBI_15982', 'cob(I)alamin', 78, 'Cobalamin'), ('CHEBI_5759', 'Honokiol', 93, 'Homocysteine'), ('NCBITaxon_10088', 'Mus <genus>', 204, 'people'), ('GO_0007631', 'feeding behavior', 221, 'consuming'), ('CHEBI_27563', 'arsenic atom', 242, 'arsenic')]
PMC2265032	3/2008	S2-PMC2265032	['Rats receiving daily doses of Arsenic equivalent to the levels in groundwater from heavily Arsenic-contaminated areas of the bengal basin retained significantly less of the element in Blood and Liver and Excreted significantly more in Urine when Fed 2 mg/ml Age.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('CHEBI_27563', 'arsenic atom', 30, 'arsenic'), ('CHEBI_27563', 'arsenic atom', 91, 'arsenic'), ('UBERON_0000178', 'blood', 184, 'blood'), ('UBERON_0002107', 'liver', 194, 'liver'), ('GO_0007588', 'excretion', 204, 'excreted'), ('UBERON_0001088', 'urine', 235, 'urine'), ('GO_0007631', 'feeding behavior', 246, 'fed'), ('CHEBI_80551', 'APC', 258, 'AGE')]
PMC2717130	7/2009	S3-PMC2717130	['Blood and Hair were collected at delivery and analyzed for Arsenic using inductively coupled Plasma mass spectrometry with dynamic reaction cell.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001037', 'strand of hair', 10, 'hair'), ('CHEBI_27563', 'arsenic atom', 59, 'arsenic'), ('UBERON_0001969', 'blood plasma', 93, 'plasma')]
PMC2717130	7/2009	S6-PMC2717130	['adjusting for age, native-american race, Prepregnancy body mass index, medicaid use, and marital status, women in the highest quartile of Blood Arsenic exposure had 2.8 higher odds of impaired gtt than women in the lowest quartile of exposure (95% confidence interval, 1.1–6.9) ( p -trend = 0.008).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 41, 'prepregnancy'), ('UBERON_0000178', 'blood', 138, 'blood'), ('CHEBI_27563', 'arsenic atom', 144, 'arsenic')]
PMC2717130	7/2009	S52-PMC2717130	['participants who were missing information on Blood Arsenic ( n = 23) or Blood Glucose ( n = 34) were excluded, leaving a total of 532 women included in this analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_27563', 'arsenic atom', 51, 'arsenic'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CHEBI_17234', 'glucose', 78, 'glucose')]
PMC2717130	7/2009	S55-PMC2717130	['laboratory measurements\nmaternal Blood and Hair samples were collected at Delivery (± 12 hr) and analyzed for total Arsenic concentration at the hsph trace metals laboratory (boston, ma).']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0001037', 'strand of hair', 43, 'hair'), ('GO_0007567', 'parturition', 74, 'delivery'), ('CHEBI_27563', 'arsenic atom', 116, 'arsenic')]
PMC2717130	7/2009	S60-PMC2717130	['total Hair Arsenic concentration was measured using previously published methods (chen et al.']	N/A	N/A	[('UBERON_0001037', 'strand of hair', 6, 'hair'), ('CHEBI_27563', 'arsenic atom', 11, 'arsenic')]
PMC2717130	7/2009	S62-PMC2717130	['the limit of detection for Hair Arsenic was 0.2 ng/g.']	N/A	N/A	[('UBERON_0001037', 'strand of hair', 27, 'hair'), ('CHEBI_27563', 'arsenic atom', 32, 'arsenic')]
PMC2717130	7/2009	S68-PMC2717130	['concentration of Arsenic was estimated using external calibration with Indium as the internal standard.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 17, 'arsenic'), ('CHEBI_30430', 'indium atom', 71, 'indium')]
PMC2717130	7/2009	S69-PMC2717130	['the limit of detection for Blood Arsenic was 0.2 μg/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_27563', 'arsenic atom', 33, 'arsenic')]
PMC2717130	7/2009	S70-PMC2717130	['quality control measures for both Blood and Hair included analysis of the following: an initial calibration verification standard [national institute of standard and technology (nist; gaithersburg, md) standard reference material #1643e (trace elements in Water)]; a Solution of 1 ng/ml standard Solution of Arsenic (nist traceable); continuous calibration standards; procedural blanks; and certified reference material gbw-07601 (Human Hair; institute of geophysical and geochemical exploration, langfang, china).']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0001037', 'strand of hair', 44, 'hair'), ('CHEBI_15377', 'water', 256, 'water'), ('CHEBI_75958', 'solution', 267, 'solution'), ('CHEBI_75958', 'solution', 296, 'solution'), ('CHEBI_27563', 'arsenic atom', 308, 'arsenic'), ('NCBITaxon_9606', 'Homo sapiens', 431, 'human'), ('UBERON_0001037', 'strand of hair', 437, 'hair')]
PMC2717130	7/2009	S73-PMC2717130	['the between-assay coefficient of variation for Arsenic was 0.1.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 47, 'arsenic')]
PMC2717130	7/2009	S74-PMC2717130	['samples with Blood Arsenic concentration < 0.2 μg/l ( n = 4; 0.7%), Hair Arsenic concentration < 0.2 ng/g ( n = 4; 2%), or insufficient sample weight for analysis ( n = 18; 10%) were reported as less than the limit of detection and not included in the analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('CHEBI_27563', 'arsenic atom', 19, 'arsenic'), ('UBERON_0001037', 'strand of hair', 68, 'hair'), ('CHEBI_27563', 'arsenic atom', 73, 'arsenic')]
PMC2717130	7/2009	S80-PMC2717130	['the Arsenic exposure measurements were grouped into quartiles and entered into the models as dummy variables, with the lowest quartile used as the reference category.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 4, 'arsenic')]
PMC2717130	7/2009	S86-PMC2717130	['linear models were also fitted using Arsenic exposure as a continuous variable and presented for an iqr increase in exposure.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 37, 'arsenic')]
PMC2717130	7/2009	S97-PMC2717130	['Hair Arsenic concentration, available on a subset of participants, ranged from 1.1 to 724.4 ng/g (ppb) ( n = 180; mean 27.4 ± 61.6) and was not significantly correlated with Blood Glucose level (spearman’s rho = 0.04; p = 0.6).']	N/A	N/A	[('UBERON_0001037', 'strand of hair', 0, 'Hair'), ('CHEBI_27563', 'arsenic atom', 5, 'arsenic'), ('UBERON_0000178', 'blood', 174, 'blood'), ('CHEBI_17234', 'glucose', 180, 'glucose')]
PMC2717130	7/2009	S98-PMC2717130	['among the subset of women with both exposure bio-markers available ( n = 179), Blood and Hair Arsenic levels were not significantly correlated with each other (spearman’s rho = −0.13; p = 0.08).']	N/A	N/A	[('UBERON_0000178', 'blood', 79, 'blood'), ('UBERON_0001037', 'strand of hair', 89, 'hair'), ('CHEBI_27563', 'arsenic atom', 94, 'arsenic')]
PMC2717130	7/2009	S103-PMC2717130	['in multivariate analyses ( n = 456), adjusting for age, native-american race/ethnicity, Prepregnancy bmi, medicaid use, and marital status, women in the highest quartile of Blood Arsenic exposure had 2.79 higher odds of impaired gtt (> 140 mg/dl) than women in the lowest quartile of exposure [95% confidence interval (ci), 1.13–6.87] (table 2).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 88, 'prepregnancy'), ('UBERON_0000178', 'blood', 173, 'blood'), ('CHEBI_27563', 'arsenic atom', 179, 'arsenic')]
PMC2717130	7/2009	S105-PMC2717130	['using the more sensitive criterion (> 130 mg/dl), women in the highest quartile of Blood Arsenic exposure had 2.35 higher odds of impaired gtt (> 130 mg/dl) than women in the lowest quartile of exposure (95% ci, 1.18–4.69) ( p -trend = 0.006).']	N/A	N/A	[('UBERON_0000178', 'blood', 83, 'blood'), ('CHEBI_27563', 'arsenic atom', 89, 'arsenic')]
PMC2721967	7/2009	S47-PMC2721967	['the sum of Metabolites of inorganic Arsenic in spot Urine samples was measured by hydride generation Atomic absorption spectroscopy and adjusted for variation in Urine dilution by specific gravity (mean 1.0012 g/ml).']	N/A	N/A	[('CHEBI_25212', 'metabolite', 11, 'metabolites'), ('CHEBI_27563', 'arsenic atom', 36, 'arsenic'), ('UBERON_0001088', 'urine', 52, 'urine'), ('CHEBI_33250', 'atom', 101, 'atomic'), ('UBERON_0001088', 'urine', 162, 'urine')]
PMC2966409	10/2010	S55-PMC2966409	["these models adjusted for infant sex, mother's age, and Arsenic exposure in the mother's drinking Water during Pregnancy."]	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 56, 'arsenic'), ('CHEBI_15377', 'water', 98, 'water'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy')]
PMC2966409	10/2010	S146-PMC2966409	['all regression models included drinking Water Arsenic exposure, infant sex and maternal age.']	N/A	N/A	[('CHEBI_15377', 'water', 40, 'water'), ('CHEBI_27563', 'arsenic atom', 46, 'arsenic')]
PMC3360698	5/2012	S12-PMC3360698	['introduction\nnaturally occurring Arsenic (as) is a ubiquitous element in the environment.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 33, 'arsenic')]
PMC3404653	3/2012	S2-PMC3404653	['methods: drinking-Water and Urine samples were collected when women were at ≤ 28 weeks Gestation; the samples were analyzed for Arsenic using inductively coupled Plasma mass spectrometry.']	N/A	N/A	[('CHEBI_15377', 'water', 18, 'water'), ('UBERON_0001088', 'urine', 28, 'urine'), ('GO_0007565', 'female pregnancy', 87, 'gestation'), ('CHEBI_27563', 'arsenic atom', 128, 'arsenic'), ('UBERON_0001969', 'blood plasma', 162, 'plasma')]
PMC3404653	3/2012	S4-PMC3404653	['we used general linear models to evaluate the relationship between Dna Methylation and tertiles of Arsenic exposure.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 67, 'DNA methylation'), ('CHEBI_27563', 'arsenic atom', 99, 'arsenic')]
PMC3404653	3/2012	S5-PMC3404653	['results: mean (± sd) drinking-Water Arsenic concentration was 14.8 ± 36.2 μg/l (range: < 1–230 μg/l).']	N/A	N/A	[('CHEBI_15377', 'water', 30, 'water'), ('CHEBI_27563', 'arsenic atom', 36, 'arsenic')]
PMC3404653	3/2012	S12-PMC3404653	['Inorganic Arsenic (As) is ubiquitous in the environment, and Individuals can be exposed to As from mining and smelting metal ores, Pesticide manufacturing and application, and wood Preservatives (mandal and suzuki 2002).']	N/A	N/A	[('CHEBI_5939', 'Interferon gamma-1b', 0, 'Inorganic'), ('CHEBI_27563', 'arsenic atom', 10, 'arsenic'), ('CHEBI_22868', 'bile salt', 19, 'As'), ('NCBITaxon_1', 'root', 61, 'individuals'), ('CHEBI_22868', 'bile salt', 91, 'As'), ('CHEBI_39207', 'spinosyn', 131, 'pesticide'), ('CHEBI_46791', 'methoxymethanol', 181, 'preservatives')]
PMC3404653	3/2012	S70-PMC3404653	['total Urinary Arsenic (tua) was calculated by adding asiii+ asv+ Mma + Dma.']	N/A	N/A	[('UBERON_0001088', 'urine', 6, 'urinary'), ('CHEBI_27563', 'arsenic atom', 14, 'arsenic'), ('CHEBI_34840', 'methyl methacrylate', 65, 'MMA'), ('CHEBI_17874', 'dihydrozeatin', 71, 'DMA')]
PMC3404653	3/2012	S76-PMC3404653	['creatinine-adjusted Urinary Arsenic concentrations were derived by dividing total Urinary Arsenic (micrograms per liter) by creatinine (grams per liter).']	N/A	N/A	[('UBERON_0001088', 'urine', 20, 'urinary'), ('CHEBI_27563', 'arsenic atom', 28, 'arsenic'), ('UBERON_0001088', 'urine', 82, 'urinary'), ('CHEBI_27563', 'arsenic atom', 90, 'arsenic')]
PMC3404653	3/2012	S92-PMC3404653	['caption (table-wrap): table 1\n\ngeneral description of the population providing maternal and Umbilical Cord Blood (n = 113).variablenmean ± sdminimummaximumcesarean section (yes)6 (5.3%)Premature (< 37 weeks)13 (11.5%)infant sex (male)50 (44.3%)Prenatal Vitamins (no)2 (1.8%)maternal age (years)11323.5 ± 4.21838maternal bmi11321.0 ± 3.113.429.0birth weight (g)1132,786 ± 3351,7403,520gestational age at enrollment (weeks)11313.3 ± 4.84.725.9maternal drinking-Water as (μg/l)11314.8 ± 36.2< 1230total Urinary as (μg/l)11325.3 ± 260.30.05260.3total Urinary as (μg/g creatinine)1131.01 ± 2.60.00421.87urinary creatinine (mg/dl)11335.6 ± 31.73.4172.8cord Blood Leukocytes (%mc)line-110980.6 ± 1.976.285.3alu11325.0 ± 0.876.085.1p16 position 11122.4 ± 1.40.879.17p16 position 21122.8 ± 1.31.086.98p16 position 31121.4 ± 0.806.09p16 position 41122.1 ± 1.00.855.82p16 position 51122.1 ± 0.91.067.66p16 position 61121.3 ± 0.805.03p16 position 71122.4 ± 1.10.886.60p53 position 11032.5 ± 0.907.91p53 position 21037.5 ± 2.82.9524.13p53 position 31032.5 ± 1.3013.22p53 position 41033.7 ± 1.5012.58maternal Blood Leukocytes (%mc)line-110180.2 ± 2.176.085.1alu10325.2 ± 0.725.527.5p16 position 11012.6 ± 1.50.6010.87p16 position 21013.1 ± 1.71.0512.51p16 position 31011.4 ± 0.603.21p16 position 41012.2 ± 1.00.735.45p16 position 51012.2 ± 0.71.234.54p16 position 61011.2 ± 0.703.22p16 position 71012.9 ± 2.21.0616.73p53 position 1912.8 ± 1.71.4015.59p53 position 2918.3 ± 2.73.9118.84p53 position 3912.8 ± 1.01.577.03p53 position 4913.8 ± 1.508.6\n\ncaption (table-wrap): table 2\n\ndistribution of Water and Urinary Arsenic concentrations.percentileminimum10th25th50th75th90thmaximumdrinking Water as (μg/l)< 1< 1< 11.23.761230total Urinary as (μg/l)0.052.675.9512.3529.5460.30260.29total Urinary as (μg as/g creatinine)0.0040.180.30.480.801.4221.87\nnon-cpg cytosine residues were used to verify Bisulfite conversion.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 92, 'umbilical cord'), ('UBERON_0000178', 'blood', 107, 'blood'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 185, 'Premature'), ('GO_0007565', 'female pregnancy', 244, 'Prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 253, 'vitamins'), ('CHEBI_15377', 'water', 459, 'water'), ('UBERON_0001088', 'urine', 500, 'urinary'), ('UBERON_0001088', 'urine', 547, 'urinary'), ('CL_0000081', 'blood cell', 651, 'blood leukocytes'), ('UBERON_0000178', 'blood', 651, 'blood'), ('CL_0000081', 'blood cell', 1095, 'blood leukocytes'), ('UBERON_0000178', 'blood', 1095, 'blood'), ('CHEBI_15377', 'water', 1582, 'water'), ('UBERON_0001088', 'urine', 1592, 'urinary'), ('CHEBI_27563', 'arsenic atom', 1600, 'arsenic'), ('CHEBI_15377', 'water', 1676, 'Water'), ('UBERON_0001088', 'urine', 1717, 'urinary'), ('UBERON_0001088', 'urine', 1773, 'urinary'), ('CHEBI_29874', 'bromine dioxide', 1880, 'bisulfite')]
PMC3404653	3/2012	S98-PMC3404653	['drinking-Water as concentrations and total Urinary Arsenic adjusted for creatinine were categorized into tertiles.']	N/A	N/A	[('CHEBI_15377', 'water', 9, 'water'), ('UBERON_0001088', 'urine', 43, 'urinary'), ('CHEBI_27563', 'arsenic atom', 51, 'arsenic')]
PMC3404653	3/2012	S105-PMC3404653	['spearman correlation coefficients were used to evaluate the relationship between Water as and creatinine-adjusted total Urinary Arsenic (tua/g).']	N/A	N/A	[('CHEBI_15377', 'water', 81, 'water'), ('UBERON_0001088', 'urine', 120, 'urinary'), ('CHEBI_27563', 'arsenic atom', 128, 'arsenic')]
PMC3404653	3/2012	S109-PMC3404653	['additionally, we evaluated the association between total Urinary Arsenic (micrograms per liter) and Dna Methylation in models that included creatinine as an independent variable [see supplemental material,table 3(http://dx.doi.org/10.1289/ehp.1104173)].']	N/A	N/A	[('UBERON_0001088', 'urine', 57, 'urinary'), ('CHEBI_27563', 'arsenic atom', 65, 'arsenic'), ('GO_0006306', 'DNA methylation', 100, 'DNA methylation')]
PMC3404653	3/2012	S176-PMC3404653	['in a Bladder cancer study conducted in new hampshire (usa), tumor suppressor Genes Rassf1A and Prss3 were hypermethylated in Bladder cancer tumors collected from 18 Individuals who had Toenail as levels at or above the 95th percentile compared with 318 tumors from Individuals with Toenail Arsenic levels below the 95th percentile (marsit et al.']	N/A	N/A	[('UBERON_0018707', 'bladder organ', 5, 'bladder'), ('SO_0000704', 'gene', 77, 'genes'), ('PR_000013795', 'RNA-binding protein 34', 83, 'RASSF1A'), ('PR_000013319', 'neurotrypsin', 95, 'PRSS3'), ('UBERON_0018707', 'bladder organ', 125, 'bladder'), ('NCBITaxon_1', 'root', 165, 'individuals'), ('UBERON_0009567', 'nail of pedal digit', 185, 'toenail'), ('NCBITaxon_1', 'root', 265, 'individuals'), ('UBERON_0009567', 'nail of pedal digit', 282, 'toenail'), ('CHEBI_27563', 'arsenic atom', 290, 'arsenic')]
PMC3404653	3/2012	S178-PMC3404653	['in Adults participating in a 12-week Folic Acid supplementation trial ( n = 294) in bangladesh, global Dna Methylation in Leukocytes increased with Urinary Arsenic levels among 104 Folate replete Adults (pilsner et al.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 3, 'adults'), ('CHEBI_30751', 'formic acid', 37, 'folic acid'), ('GO_0006306', 'DNA methylation', 103, 'DNA methylation'), ('CL_0000738', 'leukocyte', 122, 'leukocytes'), ('UBERON_0001088', 'urine', 148, 'urinary'), ('CHEBI_27563', 'arsenic atom', 156, 'arsenic'), ('CHEBI_30863', '5-azaorotic acid', 181, 'folate'), ('UBERON_0007023', 'adult organism', 196, 'adults')]
PMC3504157	11/2012	S48-PMC3504157	['[62]a case of chronic Arsenic toxicity secondary to ayurvedic medications presented with skin lesions (punctuate palmoplantar keratoderma and leucomelanoderma) and portal hypertension.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 22, 'arsenic')]
PMC3504157	11/2012	S55-PMC3504157	['[70]of the contaminated products, mercury was found in 51.4%, Arsenic in 34.8%, lead in 14.5% and copper in 0.7%.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 62, 'arsenic')]
PMC3504157	11/2012	S152-PMC3504157	['similarly, inorganic and Organic Arsenic are both naturally occurring Compounds that display different toxicities.']	N/A	N/A	[('CHEBI_77514', '6-phenylundecane', 25, 'organic'), ('CHEBI_27563', 'arsenic atom', 33, 'arsenic'), ('CHEBI_36357', 'polyatomic entity', 70, 'compounds')]
PMC3600625	2/2013	S7-PMC3600625	['no association was observed between early Arsenic or cadmium exposure and Kidney volume at 4.5 years assessed by ultrasound.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 42, 'arsenic'), ('UBERON_0002113', 'kidney', 74, 'kidney')]
PMC3600625	2/2013	S17-PMC3600625	['the minimat trial was conducted in an area with frequently elevated Arsenic concentrations in well Water, which is the drinking Water source of more than 95% of the population.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 68, 'arsenic'), ('CHEBI_15377', 'water', 99, 'water'), ('CHEBI_15377', 'water', 128, 'water')]
PMC3600625	2/2013	S26-PMC3600625	['Urinary Arsenic (u-as) during Pregnancy was measured on all available Urine samples provided by Pregnant women enrolled into the trial.']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urinary'), ('CHEBI_27563', 'arsenic atom', 8, 'arsenic'), ('GO_0007565', 'female pregnancy', 30, 'pregnancy'), ('UBERON_0001088', 'urine', 70, 'urine'), ('GO_0007565', 'female pregnancy', 96, 'pregnant')]
PMC3600625	2/2013	S29-PMC3600625	['measurements\n\nexposure assessment\nUrinary measures were chosen as the most informative as they reflect exposure from all sources including Food.4,5,22,23spot Urine samples were collected from participating women in early (median: week 8; 10th, 90th percentile: week 7, 12) and also in late (week 30; week 29, 33) Gestation.24urine samples were also collected from the children at 18 months of age (10th, 90th percentile: 17.9, 18.2 months) using plastic bags placed in potties;25only Arsenic measurements were conducted for this time point.']	N/A	N/A	[('UBERON_0001088', 'urine', 34, 'Urinary'), ('CHEBI_33290', 'food', 139, 'food'), ('UBERON_0001088', 'urine', 158, 'urine'), ('GO_0007565', 'female pregnancy', 313, 'gestation'), ('CHEBI_27563', 'arsenic atom', 484, 'arsenic')]
PMC3600625	2/2013	S61-PMC3600625	['u-as Pregnancy represents the number of Individuals with Urinary Arsenic measurements from at least one time point in Pregnancy: 8 weeks or 30 weeks of Gestation.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 5, 'pregnancy'), ('NCBITaxon_1', 'root', 40, 'individuals'), ('UBERON_0001088', 'urine', 57, 'urinary'), ('CHEBI_27563', 'arsenic atom', 65, 'arsenic'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy'), ('GO_0007565', 'female pregnancy', 152, 'gestation')]
PMC3600625	2/2013	S63-PMC3600625	['u-as 18 months refers to child Urinary Arsenic measurements at 18 months of age\n\ncaption (table-wrap): table 1\n\ncharacteristics of study cohortlost to follow-uparecruited into 4.5 y follow-upblood pressure samplegfr samplekidney volume samplenmean (sd)bnmean (sd)bnmean (sd)bnmean (sd)bmaternal characteristics\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003age (y)76826.1 (5.8)249926.6 (6.0)133426.7 (6.0)114526.6 (6.0)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003wealth indexc7250.63 (−1.76, 2.00)23860.38 (−1.65, 1.80)13320.10 (−1.93, 1.74)10380.68 (−1.26, 1.91)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003early Pregnancy (week 8) bmi (kg/m2)76720.2 (2.7)249020.1 (2.7)132819.9 (2.6)114220.3 (2.8)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Maternal Urinary Arsenic (µg/l) week 8 gest−−169280.5 (38, 208)117885 (38, 216)67570 (37, 182)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003week 30 gest−−178082.5 (42, 228)128382 (41, 228)66183 (44, 243)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003maternal Urinary cadmium(µg/l) week 8 gest−−12800.63 (0.38, 1.0)11590.63 (0.38, 1.01)2800.63 (0.41, 1.06)children characteristics,\u2003infancy\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Gestational age (weeks)76839.1 (1.9)249939.2 (1.6)133439.2 (1.7)114539.2 (1.6)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Birth weight (kg)7682.67 (0.45)24982.70 (0.40)13332.69 (0.40)11452.73 (0.40)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Birth length (cm)76748.0 (4.9)249747.86 (2.39)133248.0 (2.54)114547.74 (2.14)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Breastfeeding pattern at 4 monthsd67354.7% exclusive, 33.1% predominant248459.7% exclusive, 28.3% predominant132860.8% exclusive, 27.7% predominant113658.3% exclusive, 30.2% predominant\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Urinary Arsenic at 18 months (µg/l)−−181633.9 (18.2, 77.4)127533.6 (18.1, 76.5)70133.4 (17.9, 73.6)\u20034.5 y follow-up\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003age (y)−−24994.6 (0.14)13344.5 (0.14)11454.6 (0.10)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003male (%)−−249951.6%133452.7%114550.9%\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003height (cm)−−249999.8 (4.3)133399.6 (4.7)114599.8 (4.1)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003weight (kg)−−249913.76 (1.66)133413.67 (1.62)114513.81 (1.63)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003impedance indexe−−22660.13 (0.01)12100.13 (0.01)10260.13 (0.01)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003systolic Blood pressure (mmhg)−−249991.4 (7.6)132191.3 (7.9)113691.7 (7.5)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003diastolic Blood pressure (mmhg)−−249954.4 (6.5)132154.2 (6.8)113654.8 (6.1)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Glomerular filtration ratef(ml/min/1.73 m2)−−1321158.3 (35.2)1334158.2 (35.2)150164.0 (35.1)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Kidney volume (cm3/m2)g−−1136103.7 (15.5)150104.7 (15.1)1145103.8 (15.5)\nabbreviations: gfr, Glomerular filtration rate; bmi, body mass index.']	N/A	N/A	[('UBERON_0001088', 'urine', 31, 'urinary'), ('CHEBI_27563', 'arsenic atom', 39, 'arsenic'), ('GO_0007565', 'female pregnancy', 502, 'pregnancy'), ('UBERON_0000976', 'humerus', 595, 'Maternal'), ('UBERON_0001088', 'urine', 604, 'urinary'), ('CHEBI_27563', 'arsenic atom', 612, 'arsenic'), ('UBERON_0001088', 'urine', 777, 'urinary'), ('GO_0007565', 'female pregnancy', 914, 'Gestational'), ('GO_0007567', 'parturition', 1000, 'Birth'), ('GO_0007567', 'parturition', 1084, 'Birth'), ('UBERON_0000165', 'mouth', 1169, 'Breastfeeding'), ('UBERON_0001088', 'urine', 1362, 'Urinary'), ('CHEBI_27563', 'arsenic atom', 1370, 'arsenic'), ('UBERON_0000178', 'blood', 1801, 'blood'), ('UBERON_0000178', 'blood', 1884, 'blood'), ('UBERON_0000074', 'renal glomerulus', 1957, 'Glomerular'), ('UBERON_0002113', 'kidney', 2057, 'Kidney'), ('UBERON_0000074', 'renal glomerulus', 2150, 'glomerular')]
PMC3600625	2/2013	S73-PMC3600625	['median maternal Urinary Arsenic was 80 µg/l (10th, 90th percentile: 24, 383 µg/l) at week 8 of Gestation and 83 µg/l (10th, 90th: 26, 415 µg/l) at week 30.']	N/A	N/A	[('UBERON_0001088', 'urine', 16, 'urinary'), ('CHEBI_27563', 'arsenic atom', 24, 'arsenic'), ('GO_0007565', 'female pregnancy', 95, 'gestation')]
PMC3600625	2/2013	S75-PMC3600625	['at 18 months, median Urinary Arsenic was 34 µg/l (10th, 90th: 12, 154 µg/l).']	N/A	N/A	[('UBERON_0001088', 'urine', 21, 'urinary'), ('CHEBI_27563', 'arsenic atom', 29, 'arsenic')]
PMC3600625	2/2013	S94-PMC3600625	['there was no interaction between either the Prenatal Food or multiple-Micronutrient intervention and the effect of Urinary Arsenic and cadmium on any of the outcomes studied (data not shown).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 44, 'prenatal'), ('CHEBI_33290', 'food', 53, 'food'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 70, 'micronutrient'), ('UBERON_0001088', 'urine', 115, 'urinary'), ('CHEBI_27563', 'arsenic atom', 123, 'arsenic')]
PMC3600625	2/2013	S106-PMC3600625	['the average Arsenic exposure in Pregnancy, i.e.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 12, 'arsenic'), ('GO_0007565', 'female pregnancy', 32, 'pregnancy')]
PMC3600625	2/2013	S128-PMC3600625	['Kidney volume was not affected by Arsenic or cadmium exposure in this study.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('CHEBI_27563', 'arsenic atom', 34, 'arsenic')]
PMC3704911	7/2013	S216-PMC3704911	['the drinking Water quality report for downey, ca warns of 20 different Pollutants in the city’s Water, with eight chemicals existing at concentrations that exceed the health guidelines set by federal and state agencies: tri - and tetro-chloroethylene (dbas), alpha particle activity, Arsenic, Radium 228, lead, radium 226, and combined radium [66].']	N/A	N/A	[('CHEBI_15377', 'water', 13, 'Water'), ('CHEBI_26199', 'polyprenol', 71, 'pollutants'), ('CHEBI_15377', 'water', 96, 'water'), ('CHEBI_27563', 'arsenic atom', 284, 'arsenic'), ('CHEBI_33325', 'radium atom', 293, 'radium')]
PMC3821942	10/2013	S132-PMC3821942	['all brewed tea and tea leaves had detectable Arsenic with chinese oolong teas (organic or regular) having the highest levels.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 45, 'arsenic')]
PMC3915248	2/2014	S48-PMC3915248	['Arsenic is chemically very similar to zinc and can replace zinc in proteins that are important in Dna Repair.41“Arsenic goes in and kicks zinc out, but the Arsenic doesn’t replace the function of zinc.']	N/A	N/A	[('CHEBI_85195', '9,10-epoxyoctadecanoate', 0, 'Arsenic'), ('GO_0006281', 'DNA repair', 98, 'DNA repair'), ('CHEBI_85195', '9,10-epoxyoctadecanoate', 112, 'Arsenic'), ('CHEBI_27563', 'arsenic atom', 156, 'arsenic')]
PMC4021291	4/2014	S2-PMC4021291	['at enrollment (<16\xa0weeks Gestational age [wga]), Arsenic was measured in personal drinking Water using inductively-coupled Plasma mass spectrometry.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 25, 'gestational'), ('CHEBI_27563', 'arsenic atom', 49, 'arsenic'), ('CHEBI_15377', 'water', 91, 'water'), ('UBERON_0001969', 'blood plasma', 123, 'plasma')]
PMC4021291	4/2014	S4-PMC4021291	['adjusted odds ratios (aors) and 95% confidence intervals (95% ci) for self-reported health symptoms were estimated for each Arsenic quartile using logistic regression.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 124, 'arsenic')]
PMC4021291	4/2014	S5-PMC4021291	['results\noverall, the mean concentration of Arsenic was 38\xa0μg/l (standard deviation, 92.7\xa0μg/l).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 43, 'arsenic')]
PMC4021291	4/2014	S7-PMC4021291	['compared to participants exposed to the lowest quartile of Arsenic (≤0.9\xa0μg/l), the aor for reporting any symptom during Pregnancy was 0.62 (95% ci\u2009=\u20090.44-0.88) in the second quartile, 1.83 (95% ci\u2009=\u20091.25-2.69) in the third quartile, and 2.11 (95% ci\u2009=\u20091.42-3.13) in the fourth quartile where the mean Arsenic concentration in each quartile was 1.5\xa0μg/l, 12.0\xa0μg/l and 144.7\xa0μg/l, respectively.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 59, 'arsenic'), ('GO_0007565', 'female pregnancy', 121, 'pregnancy'), ('CHEBI_27563', 'arsenic atom', 302, 'arsenic')]
PMC4021291	4/2014	S9-PMC4021291	['the odds of self-reported nausea/vomiting was 0.98 (95% ci: 0.68, 1.41), 1.52 (95% ci: 1.05, 2.18), and 1.81 (95% ci: 1.26, 2.60) in the second, third and fourth quartile of Arsenic relative to the lowest quartile after adjusting for age, body mass index, second-hand tobacco smoke exposure, educational status, parity, anemia, ferritin, medication usage, type of sanitation at home, and household income.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 174, 'arsenic')]
PMC4021291	4/2014	S15-PMC4021291	['background\nInorganic Arsenic is a ubiquitous environmental Pollutant.']	N/A	N/A	[('CHEBI_5939', 'Interferon gamma-1b', 11, 'Inorganic'), ('CHEBI_27563', 'arsenic atom', 21, 'arsenic'), ('CHEBI_75260', 'penicillinate salt', 59, 'pollutant')]
PMC4021291	4/2014	S16-PMC4021291	['People can be exposed to Arsenic from occupational activities, Eating contaminated foods, and from industrial sources [1].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'People'), ('CHEBI_27563', 'arsenic atom', 25, 'arsenic'), ('GO_0051318', 'G1 phase', 63, 'eating')]
PMC4021291	4/2014	S34-PMC4021291	['additionally, dhaka community hospital trust (dch) operates rural health clinics in these upazilas that offer Prenatal care and promote Arsenic awareness by encouraging People to only drink Water from wells that comply with the bangladesh drinking Water standard of\u2009≤\u200950\xa0μg as/l.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 110, 'prenatal'), ('CHEBI_27563', 'arsenic atom', 136, 'arsenic'), ('NCBITaxon_10088', 'Mus <genus>', 169, 'people'), ('CHEBI_15377', 'water', 190, 'water'), ('CHEBI_15377', 'water', 248, 'water')]
PMC4021291	4/2014	S35-PMC4021291	['in addition to medical staff, each clinic has trained technicians who provided field testing of Arsenic in well Water upon request.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 96, 'arsenic'), ('CHEBI_15377', 'water', 112, 'water')]
PMC4021291	4/2014	S52-PMC4021291	['during the consent procedure all participants were informed of the hazards posed by Arsenic exposure using language that was consistent with the ongoing Arsenic awareness campaigns (e.g.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 84, 'arsenic'), ('CHEBI_27563', 'arsenic atom', 153, 'arsenic')]
PMC4021291	4/2014	S53-PMC4021291	['Arsenic is a poison found in the groundwater that causes diseases of the skin and other Parts of the body).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 0, 'arsenic'), ('UBERON_0001372', 'psoas minor muscle', 88, 'parts')]
PMC4021291	4/2014	S56-PMC4021291	['participants could request that their Water be tested for Arsenic using merck (doubling method) field test kits by clinic staff [21].']	N/A	N/A	[('CHEBI_15377', 'water', 38, 'water'), ('CHEBI_27563', 'arsenic atom', 58, 'arsenic')]
PMC4021291	4/2014	S59-PMC4021291	['additionally, all participants were informed of the concentration of Arsenic in their drinking Water after it was analyzed by inductively coupled Plasma mass spectrometry.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 69, 'arsenic'), ('CHEBI_15377', 'water', 95, 'water'), ('UBERON_0001969', 'blood plasma', 146, 'plasma')]
PMC4021291	4/2014	S65-PMC4021291	['of the 1237 samples included in this analysis, 252 (20.4%) had an Arsenic concentration below the 1\xa0μg as/l limit of detection (lod).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 66, 'arsenic')]
PMC4021291	4/2014	S81-PMC4021291	['Drinking Water Arsenic concentrations were transformed using the natural log and also categorized into quartiles.']	N/A	N/A	[('GO_0006307', 'DNA dealkylation involved in DNA repair', 0, 'Drinking'), ('CHEBI_15377', 'water', 9, 'water'), ('CHEBI_27563', 'arsenic atom', 15, 'arsenic')]
PMC4021291	4/2014	S83-PMC4021291	['logistic regression models were used to compute the relative odds and 95% confidence intervals of experiencing a symptom at least once during Pregnancy for increasing quartiles of Arsenic.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 142, 'pregnancy'), ('CHEBI_27563', 'arsenic atom', 180, 'arsenic')]
PMC4021291	4/2014	S84-PMC4021291	['additionally, we constructed logistic regression models to compute the odds of self-reported symptoms for Arsenic concentrations dichotomized at regulatory drinking Water Arsenic limits (below/above 10\xa0μg/l and below/above 50\xa0μg/l).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 106, 'arsenic'), ('CHEBI_15377', 'water', 165, 'water'), ('CHEBI_27563', 'arsenic atom', 171, 'arsenic')]
PMC4021291	4/2014	S89-PMC4021291	['there was no significant difference in the age (22.8 vs 22.9\xa0years, p-value\u2009=\u20090.51), ln drinking Water Arsenic (1.3 vs 1.7\xa0μg/l, p-value 0.27), parity (0.7 vs 0.7, p-value\u2009=\u20090.76), bmi at the time of enrollment (20.8 vs 20.5, p-value\u2009=\u20090.42), or maternal education (p-value\u2009=\u20090.14) among participants who were lost to follow up and those who were included in this analysis.']	N/A	N/A	[('CHEBI_15377', 'water', 97, 'water'), ('CHEBI_27563', 'arsenic atom', 103, 'arsenic')]
PMC4021291	4/2014	S92-PMC4021291	['at the time of enrollment, the overall mean and median concentration of Arsenic in participant’s drinking Water was 38\xa0μg/l (standard deviation, 92.7\xa0μg/l) and 2\xa0μg/l (interquartile range, 30\xa0μg/l), respectively.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 72, 'arsenic'), ('CHEBI_15377', 'water', 106, 'water')]
PMC4021291	4/2014	S97-PMC4021291	['caption (table-wrap): table 1\n\ncharacteristics of 1,262 participants that reported experiencing any symptom during Pregnancy versus no symptoms (2008–2010)\xa0 reporting any symptom \xa0\xa0 no(n\u2009=\u2009467)yes(n\u2009=\u2009795)p-valuemean (sd), Arsenic at enrollment (μg/l) 20.9 (70.8)50.0 (104.1) <0.0001median (iqr), Arsenic at enrollment (μg/l) 1.6 (0.8, 5.2)7.0 (1.1, 58.0) <0.0001amean (sd) age at enrollment (yrs) 22.6 (4.0)23.1 (4.3) 0.05 \xa0 (n) %(n) % \xa0 drinking Water Arsenic quartiles \xa0\xa0\xa0\u2003q4 (mean: 144.7\xa0μg/l, range: 32–1,400\xa0μg/l) (68) 14.56 (244) 30.69 <0.0001 \u2003q3 (mean: 12.0\xa0μg/l, range: 2.1–31\xa0μg/l) (77) 16.49 (226) 28.43\xa0\u2003q2 (mean: 1.5\xa0μg/l; range: 0.9–2\xa0μg/l (185) 39.61 (142) 17.86\xa0\u2003q1 (mean: 0.7\xa0μg/l; range: 0.5–0.89\xa0μg/l) (137) 29.34 (183) 23.02\xa0 bmi at time of enrollment (kg/m2) \xa0\xa0\xa0\u2003<18.5 (117) 25.05 (246) 30.94 0.05 \u200318.5–24.9 (299) 64.03 (481) 60.5\xa0\u2003≥ 25.0 (51) 10.92 (68) 8.55\xa0 environmental tobacco smoke \xa0\xa0\xa0\u2003absent (319) 68.6 (418) 52.64 <0.001 \u2003present (146) 31.4 (376) 47.36\xa0\u2003 missing21 \xa0 maternal education \xa0\xa0\xa0\u2003illiterate/able to write name (47) 10.13 (144) 18.14 <0.0001 \u2003primary education (199) 42.89 (216) 27.2\xa0\u2003≥ secondary education (218) 46.98 (434) 54.66\xa0\u2003 missing31 \xa0 parity \xa0\xa0\xa0\u20030 (214) 45.82 (309) 38.87 0.01 \u20031-2 (213) 45.61 (385) 48.43\xa0\u2003≥3 (40) 8.57 (101) 12.7\xa0 anemia (hemoglobin\u2009≤\u200912\xa0g/dl) \xa0\xa0\xa0\u2003no (327) 70.32 (647) 81.49 <0.0001 \u2003yes (138) 29.68 (147) 18.51\xa0\u2003 missing21 \xa0 ferritin \xa0\xa0\xa0\u2003severe deficiency (<20\xa0μg/l) (80) 18.06 (108) 14.3 0.0007 \u2003mild deficiency (20–40\xa0μg/l) (138) 31.15 (179) 23.71\xa0\u2003none (>40\xa0μg/l) (225) 50.79 (468) 61.99\xa0\u2003 missing2440 \xa0 sanitation at home \xa0\xa0\xa0\u2003sanitary latrine (372) 79.83 (469) 59.14 <0.0001 \u2003other (94) 20.17 (324) 40.86\xa0\u2003 missing 12\xa0 taking herbs/medication \xa0\xa0\xa0\u2003no (459) 98.5 (719) 90.44 <0.0001 \u2003yes (7) 1.5 (76) 9.56\xa0\u2003 missing10 \xa0 income (taka/month) \xa0\xa0\xa0\u2003<3000 (45) 9.89 (176) 22.34 <0.0001 \u20033001–5000 (270) 59.34 (412) 52.28\xa0\u2003≥ 5000 (137) 30.11 (175) 22.21\xa0\u2003refused/don’t know (3) 0.66 (25) 3.17\xa0\u2003 missing127 \xa0\nawilcoxon test performed on natural log transformed values.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27563', 'arsenic atom', 223, 'arsenic'), ('CHEBI_27563', 'arsenic atom', 297, 'arsenic'), ('CHEBI_15377', 'water', 448, 'water'), ('CHEBI_27563', 'arsenic atom', 454, 'arsenic')]
PMC4021291	4/2014	S98-PMC4021291	['frequencies of specific symptoms by categories of Arsenic exposure and select characteristics are presented in table\xa02.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 50, 'arsenic')]
PMC4021291	4/2014	S101-PMC4021291	['no difference in Arsenic exposure was observed between participants who reported Vaginal bleeding or swollen Ankles.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 17, 'arsenic'), ('UBERON_0001987', 'placenta', 81, 'vaginal'), ('UBERON_0004454', 'tarsal region', 109, 'ankles')]
PMC4021291	4/2014	S103-PMC4021291	['caption (table-wrap): table 2\n\nassociations specific symptoms and select characteristics of 1,262 mothers that were followed throughout Pregnancy (2008–2010)\xa0 cold/flu/infectionnausea/vomitingabdominal crampingheadache \xa0 no(n\u2009=\u20091035)yes(n\u2009=\u2009227)p-valueno(n\u2009=\u2009762)yes(n\u2009=\u2009500)p-valueno (n\u2009=\u2009794 )yes (n\u2009=\u2009468)p-valueno (n\u2009=\u2009850)yes (n\u2009=\u2009412)p-valuemedian (iqr) ln Arsenic (μg/l) 0.69 (−0.13, 3.47)0.53 (−0.15, 2.83) 0.11 0.59 (−0.19, 2.91)1.96 (0.18, 4.11) <0.001 0.59 (−0.17, 2.71)2.39 (0.18, 4.21) <0.001 0.64 (−0.11, 3.26)1.02 (−0.15, 3.81) 0.23mean (sd) age (yrs) 22.8 (4.1)23.1 (4.6) 0.46 22.7 (4.1)23.1 (4.4) 0.09 22.8 (4.2)23 (4.1) 0.56 22.9 (4.2)22.8 (4.1) 0.73 \xa0 (n)%(n)% \xa0 (n) %(n) % \xa0 (n) %(n) % \xa0 (n) %(n) % \xa0 drinking Water Arsenic quartiles \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0q4 (high) (264) 25.51 (48) 21.15 0.26(152) 19.95 (160) 32.0 <0.001(150) 18.89 (162) 34.62 <0.001(195) 22.94 (117) 28.4 0.04 q3 (249) 24.06 (54) 23.79\xa0 (163) 21.39 (140) 28.0\xa0 (163) 20.53 (140) 29.91\xa0 (205) 24.12 (98) 23.79\xa0q2 (260) 25.12 (67) 29.52\xa0 (231) 30.31 (96) 19.2\xa0 (262) 33.0 (65) 13.89\xa0 (239) 28.12 (88) 21.36\xa0q1 (low) (262) 25.31 (58) 25.55\xa0 (216) 28.35 (104) 20.8\xa0 (219) 27.58 (101) 21.58\xa0 (211) 24.82 (109) 26.46\xa0 bmi (kg/m2) \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0<18.5 (295) 28.5 (68) 29.96 0.07(206) 27.03 (157) 31.4 0.24(214) 26395 (149) 31.84 0.10(243) 28.59 (120) 29.13 0.87 18.5-24.9 (651) 62.9 (129) 56.83\xa0 (481) 63.12 (299) 59.8\xa0 (498) 62.72 (282) 60.26\xa0 (529) 62.24 (251) 60.92\xa0≥ 25.0 (89) 8.6 (30) 13.22\xa0 (75) 9.84 (44) 8.8\xa0 (82) 10.33 (37) 7.91\xa0 (78) 9.18 (41) 9.95\xa0 Second Hand smoke \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0absent (622) 60.27 (115) 50.66 0.008(487) 64.16 (250) 50.0 <0.001(485) 61.24 (252) 53.96 0.01(524) 61.79 (213) 51.82 0.0008 present (410) 39.73 (112) 49.34\xa0 (272) 35.84 (250) 50.0\xa0 (307) 38.76 (215) 46.04\xa0 (324) 38.21 (198) 48.18\xa0 num.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 136, 'pregnancy'), ('CHEBI_27563', 'arsenic atom', 363, 'arsenic'), ('CHEBI_15377', 'water', 730, 'water'), ('CHEBI_27563', 'arsenic atom', 736, 'arsenic'), ('UBERON_0007381', 'epidermal scale', 1530, 'Second'), ('UBERON_0002398', 'manus', 1537, 'hand')]
PMC4021291	4/2014	S110-PMC4021291	['missing 172\xa0145\xa0163\xa0163\xa0\nthe association between symptoms and quartiles of Arsenic exposure from adjusted logistic regression models are presented in table\xa03.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 75, 'arsenic')]
PMC4021291	4/2014	S111-PMC4021291	['the odds of a woman reporting any symptom during Pregnancy were higher among those participants with the highest Arsenic concentration in their drinking Water.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('CHEBI_27563', 'arsenic atom', 113, 'arsenic'), ('CHEBI_15377', 'water', 153, 'water')]
PMC4021291	4/2014	S113-PMC4021291	['compared to the lowest quartile of Arsenic, the adjusted odds ratio for any symptom during Pregnancy was 0.62 (95% ci: 0.44, 0.88) for the second quartile, 1.83 (95% ci: 1.25, 2.69) for the third quartile, and 2.11 (95% ci: 1.42, 3.13) for the fourth quartile.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 35, 'arsenic'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy')]
PMC4021291	4/2014	S115-PMC4021291	['the odds of self-reported nausea/vomiting was 0.98 (95% ci: 0.68, 1.41), 1.52 (95% ci: 1.05, 2.18), and 1.81 (95% ci: 1.26, 2.60) in the second, third and fourth quartile of Arsenic relative to the lowest quartile after adjusting for age, body mass index, second-hand tobacco smoke exposure, educational status, parity, anemia, ferritin, medication usage, type of sanitation at home, and household income.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 174, 'arsenic')]
PMC4021291	4/2014	S117-PMC4021291	['caption (table-wrap): table 3\n\nassociations between quartiles of Arsenic exposure and odds of self-reported symptoms during Pregnancy for women that were followed throughout Pregnancy\xa0 any symptomcold/flu/infectionnausea/vomitingabdominal crampingheadache \xa0 crude oraorcrude oraorcrude oraorcrude oraorcrude oraor(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci) Water Arsenic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\u2003q4 (high)2.69 (1.90–3.81)2.11 (1.42–3.13)0.82 (0.54–1.25)0.71 (0.45–1.14)2.19 (1.58–3.02)1.81 (1.26–2.60)2.34 (1.69–3.24)1.62 (1.13–2.32)1.16 (0.84–1.61)1.11 (0.77–1.90)\u2003q32.20 (1.56, 3.09)1.83 (1.25–2.69)0.98 (0.65–1.48)0.88 (0.55–1.39)1.78 (1.29–2.47)1.52 (1.05–2.18)1.86 (1.34–2.58)1.31 (0.91–1.88)0.93 (0.66–1.29)0.86 (0.59–1.25)\u2003q20.58 (0.42–0.78)0.62 (0.44–0.88)1.16 (0.79–1.72)1.30 (0.85–1.99)0.86 (0.62–1.21)0.98 (0.68–1.41)0.54 (0.38–0.77)0.55 (0.37–0.81)0.71 (0.51–1.00)0.77 (0.53–1.10)\u2003q1 (low)1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 reftest for trend<0.0001<0.00010.420.08<0.00010.001<0.0001<0.00010.040.19\nadjusted models include age, bmi, second-hand smoke exposure, maternal educational status, parity, anemia status, ferritin status, type of sanitation used at home, use of herbal remedy or medication, and household income.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 65, 'arsenic'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('GO_0007565', 'female pregnancy', 174, 'pregnancy'), ('CHEBI_15377', 'water', 394, 'Water'), ('CHEBI_27563', 'arsenic atom', 400, 'arsenic')]
PMC4021291	4/2014	S118-PMC4021291	['the average Arsenic concentration and range for each quartile is: q4\u2009=\u2009144.7\xa0μg/l (32\xa0μg/l – 1,400\xa0μg/l); q3\u2009=\u200912.0\xa0μg/l (2.1\xa0μg/l – 31\xa0μg/l); q2\u2009=\u20091.5\xa0μg/l (0.9\xa0μg/l – 2.0\xa0μg/l); and q1\u2009=\u20090.7\xa0μg/l (0.5\xa0μg/l – 0.89\xa0μg/l).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 12, 'arsenic')]
PMC4021291	4/2014	S120-PMC4021291	['among participants whose drinking Water contained Arsenic greater than or equal to 50\xa0μg/l, odds of reporting any symptom were two-fold higher than participants whose drinking Water contained less than 50\xa0μg/l after adjusting for age, bmi, second-hand tobacco exposure, educational status, parity, anemia, ferritin, household sanitation, medication usage, and household income (aor: 2.11; 95% ci: 1.47, 3.02).']	N/A	N/A	[('CHEBI_15377', 'water', 34, 'water'), ('CHEBI_27563', 'arsenic atom', 50, 'arsenic'), ('CHEBI_15377', 'water', 176, 'water')]
PMC4021291	4/2014	S121-PMC4021291	['the adjusted odds of nausea/Vomiting (aor: 1.47; 95% ci: 1.09, 1.98) and Abdominal cramping (aor: 1.79; 95% ci: 1.31, 2.45) was also significantly higher among participants whose drinking Water contained Arsenic ≥50\xa0μg/l compared\u2009<\u200950\xa0μg/l.']	N/A	N/A	[('GO_0006909', 'phagocytosis', 28, 'vomiting'), ('UBERON_0000916', 'abdomen', 73, 'abdominal'), ('CHEBI_15377', 'water', 188, 'water'), ('CHEBI_27563', 'arsenic atom', 204, 'arsenic')]
PMC4021291	4/2014	S122-PMC4021291	['caption (table-wrap): table 4\n\nassociation between Arsenic exposure categorized above/below 50\xa0μg/l and self-reported symptoms during Pregnancy in 1,262 women recruited in bangladesh from multiple logistic regression models (2008–2011)\xa0 any symptomcold/flu/infectionnausea/vomitingabdominal crampingsevere headache \xa0 crude oradjusted orcrude oradjusted orcrude oradjusted orcrude oradjusted orcrude oradjusted or(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci) Water Arsenic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0above 50\xa0μg/l2.76 (1.98, 3.83)2.11 (1.47, 3.02)0.87 (0.60, 1.26)0.78 (0.52, 1.16)1.85 (1.40, 2.43)1.47 (1.09, 1.98)2.19 (1.63, 2.94)1.79 (1.31, 2.45)1.34 (1.01, 1.78)1.25 (0.92, 1.71)below 50\xa0μg/l1.01.01.01.01.01.01.01.01.01.0\nadjusted models include age, bmi, second-hand smoke exposure, maternal educational status, parity, anemia status, ferritin status, type of sanitation used at home, use of herbal remedy or medication, and household income.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 51, 'arsenic'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('CHEBI_15377', 'water', 493, 'Water'), ('CHEBI_27563', 'arsenic atom', 499, 'arsenic')]
PMC4021291	4/2014	S128-PMC4021291	['caption (table-wrap): table 5\n\nassociation between Arsenic exposure categorized above/below 10\xa0μg/l and self-reported symptoms during Pregnancy in 1,262 women recruited in bangladesh from multiple logistic regression models (2008–2011)\xa0 any symptomcold/flu/infectionnausea/vomitingabdominal crampingsevere headache \xa0 crude oradjusted orcrude oradjusted orcrude oradjusted orcrude oradjusted orcrude oradjusted or(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci) Water Arsenic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0above 10\xa0μg/l3.57 (2.73, 4.66)2.99 (2.21, 4.04)0.73 (0.54, 0.99)0.61 (0.43, 0.86)2.02 (1.60, 2.55)1.62 (1.25, 2.10)2.83 (2.20, 3.64)2.39 (1.83, 3.13)1.30 (1.02, 1.65)1.14 (0.87, 1.50)below 10\xa0μg/l1.01.01.01.01.01.01.01.01.01.0\nadjusted models include age, bmi, second-hand smoke exposure, maternal educational status, parity, anemia status, ferritin status, type of sanitation used at home, use of herbal remedy or medication, and household income.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 51, 'arsenic'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('CHEBI_15377', 'water', 493, 'Water'), ('CHEBI_27563', 'arsenic atom', 499, 'arsenic')]
PMC4021291	4/2014	S135-PMC4021291	['caption (table-wrap): table 6\n\nassociations between quartiles of Arsenic exposure and odds of self-reported symptoms during Pregnancy in a subpopulation of women who did not report taking prescription or herbal medication during Pregnancy (n\u2009=\u20091,166)\xa0 any symptomcold/flu/infectionnausea/vomitingabdominal crampingheadachewater Arseniccrude oraorcrude oraorcrude oraorcrude oraorcrude oraor(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci)(95% ci) \u2003q4 (high)2.84 (1.98–4.07)2.33 (1.56–3.50)0.79 (0.50–1.27)0.79 (0.47–1.31)2.17 (1.54–3.06)1.86 (1.27–2.71)2.49 (1.77–3.51)1.80 (1.23–2.62)1.14 (0.81–1.62)1.09 (0.74–1.61)\u2003q32.35 (1.66, 3.34)2.06 (1.39–3.05)0.96 (0.61–1.51)0.91 (0.55–1.51)1.78 (1.27–2.51)1.55 (1.06–2.27)1.96 (1.39–2.76)1.45 (0.99–2.13)0.97 (0.68–1.38)0.91 (0.61–1.35)\u2003q20.60 (0.44–0.83)0.64 (0.45–0.92)1.30 (0.86–1.98)1.47 (0.94–2.32)0.86 (0.61–1.22)0.94 (0.64–1.37)0.55 (0.37–0.80)0.55 (0.37–0.83)0.72 (0.50–1.02)0.79 (0.54–1.16)\u2003q1 (low)1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref 1.0 ref test for trend<0.0001<0.00010.130.39<0.00010.0007 <0.0001<0.00010.040.37\nadjusted models include age, bmi, second-hand smoke exposure, maternal educational status, parity, anemia status, ferritin status, type of sanitation used at home, use of herbal remedy or medication, and household income.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 65, 'arsenic'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('GO_0007565', 'female pregnancy', 229, 'pregnancy'), ('CHEBI_35820', 'antiprotozoal drug', 328, 'arsenicCrude')]
PMC4021291	4/2014	S136-PMC4021291	['the average Arsenic concentration and range for each quartile is: q4\u2009=\u2009142.8\xa0μg/l (32\xa0μg/l – 1,400\xa0μg/l); q3\u2009=\u200911.9\xa0μg/l (2.1\xa0μg/l – 31\xa0μg/l); q2\u2009=\u20091.5\xa0μg/l (0.9\xa0μg/l – 2.0\xa0μg/l); and q1\u2009=\u20090.7\xa0μg/l (0.5\xa0μg/l – 0.89\xa0μg/l).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 12, 'arsenic')]
PMC4021291	4/2014	S158-PMC4021291	['additionally, participants did not know the concentration of Arsenic in their drinking Water prior to enrolling in the study.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 61, 'arsenic'), ('CHEBI_15377', 'water', 87, 'water')]
PMC4021291	4/2014	S178-PMC4021291	['the average Arsenic concentration and range for each quartile is: q4 = 139.7 μg/l (28.9 μg/l – 1,400 μg/l); q3 = 10.5 μg/l (2.0 μg/l – 28 μg/l); q2 = 1.5 μg/l (0.9 μg/l – 1.9 μg/l); and q1 = 0.71 μg/l (0.5 μg/l – 0.87 μg/l).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 12, 'arsenic')]
PMC4021291	4/2014	S181-PMC4021291	['the average Arsenic concentration and range for each quartile is: q4 = 140.9 μg/l (28.9 μg/l – 1,400 μg/l); q3 = 10.5 μg/l (2.0 μg/l – 28 μg/l); q2 = 1.5 μg/l (0.9 μg/l – 1.9 μg/l); and q1 = 0.7 μg/l (0.5 μg/l – 0.87 μg/l).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 12, 'arsenic')]
PMC4026129	1/2014	S62-PMC4026129	['worldwide, the most prevalent source of Arsenic exposure in Humans is drinking Water contaminated with inorganic Arsenic (ias), which exists in two oxidation states, namely pentavalent Arsenate (iasv) and trivalent Arsenite (iasiii).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 40, 'arsenic'), ('NCBITaxon_9606', 'Homo sapiens', 60, 'humans'), ('CHEBI_15377', 'water', 79, 'water'), ('CHEBI_27563', 'arsenic atom', 113, 'arsenic'), ('CHEBI_29125', 'arsenate(3-)', 185, 'arsenate'), ('CHEBI_29866', 'arsenite(3-)', 215, 'arsenite')]
PMC4026129	1/2014	S65-PMC4026129	['in this process, iasiiiundergoes an Oxidative Methylation step catalyzed by Arsenic (+3 oxidation state) methyltransferase (as3mt) to produce Monomethylarsonic Acid (Mmav).']	N/A	N/A	[('GO_0035514', 'DNA demethylase activity', 36, 'oxidative methylation'), ('CHEBI_27563', 'arsenic atom', 76, 'arsenic'), ('CHEBI_25418', 'morphinane alkaloid', 142, 'monomethylarsonic acid'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 166, 'MMAV')]
PMC4143751	8/2014	S82-PMC4143751	['combined exposure of Mouse fetuses to Arsenic and maternal ms, in the form of Folate, led to more pronounced Dna Methylation changes in the Liver and corresponding impaired Fetal development and body weight gain (tsang et al.,2012).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 21, 'mouse'), ('CHEBI_27563', 'arsenic atom', 38, 'arsenic'), ('CHEBI_30863', '5-azaorotic acid', 78, 'folate'), ('GO_0006306', 'DNA methylation', 109, 'DNA methylation'), ('UBERON_0002107', 'liver', 140, 'liver'), ('GO_0007631', 'feeding behavior', 173, 'fetal')]
PMC4216381	10/2014	S8-PMC4216381	['results\ndrinking Water Arsenic concentrations ranged from 0.0 to 175.1\xa0μg/l, with median 0.4\xa0μg/l and 90th%tile 9.4\xa0μg/l.']	N/A	N/A	[('CHEBI_15377', 'water', 17, 'water'), ('CHEBI_27563', 'arsenic atom', 23, 'arsenic')]
PMC4216381	10/2014	S14-PMC4216381	['background\nthe Consumption of contaminated Groundwater is the primary source of Human exposure to inorganic Arsenic (ias), a highly toxic Metalloid present naturally in the earth’s crust [1].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 15, 'consumption'), ('UBERON_0002391', 'lymph', 43, 'groundwater'), ('NCBITaxon_9606', 'Homo sapiens', 80, 'human'), ('CHEBI_27563', 'arsenic atom', 108, 'arsenic'), ('CHEBI_6794', 'metaraminol', 138, 'metalloid')]
PMC4216381	10/2014	S37-PMC4216381	['Urine specimens, for a future speciated Arsenic analysis, and Blood specimens for future Genetic and nutritional analyses were collected at the time of the interview, and archived at -20\xa0c.\n\nWater analysis\ntrained study staff collected drinking Water samples on-site into 50\xa0ml screw-top Polyethylene containers previously decontaminated with Nitric Acid (Hno3) and rinsed.']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urine'), ('CHEBI_27563', 'arsenic atom', 40, 'arsenic'), ('UBERON_0000178', 'blood', 62, 'blood'), ('SO_0000704', 'gene', 89, 'genetic'), ('CHEBI_15377', 'water', 191, 'Water'), ('CHEBI_15377', 'water', 245, 'water'), ('CHEBI_53551', 'poly(methylene)', 288, 'polyethylene'), ('CHEBI_48107', 'nitric acid', 343, 'nitric acid'), ('CHEBI_36275', 'HETE', 356, 'HNO3')]
PMC4216381	10/2014	S78-PMC4216381	['caption (table-wrap): table 2\n\ndistribution of inorganic Arsenic (Ias) exposure indices by case–control statusfactorcases (n\u2009=\u2009150)controls (n\u2009=\u2009150)p-valueameanmedianrangemeanmedianrangedaily Water Consumption (l)b1.491.500.5-5.01.261.200.0-4.00.002average ias (μg/l)c4.060.170-175.104.321.280-130.300.169peak ias (μg/l)d4.640.170-175.104.992.270-130.300.121daily ias (μg/day)e7.100.240-350.205.161.450-83.150.130\nawilcoxon signed-rank test;baverage Water consumed from non-bottled sources, including direct Consumption, teas, coffees, mixed beverages and soups;cmean ias level measured in up to two residential drinking Water sources;dthe highest Ias concentration measured in up to two residential drinking Water sources;eproduct of ‘daily Water Consumption’ multiplied by ‘average Ias.’\n\nmultivariable analyses\nwe generated logistic regression models for each of three drinking Water ias indices as predictors, conditioned on Gestational age, and adjusted for maternal age, cigarette smoking during Pregnancy, education and Prenatal vitamin use (table\xa03).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 57, 'arsenic'), ('CHEBI_24870', 'ion', 66, 'iAs'), ('CHEBI_15377', 'water', 193, 'water'), ('GO_0007631', 'feeding behavior', 199, 'consumption'), ('CHEBI_15377', 'water', 451, 'water'), ('GO_0007631', 'feeding behavior', 509, 'consumption'), ('CHEBI_15377', 'water', 622, 'water'), ('CHEBI_24870', 'ion', 649, 'iAs'), ('CHEBI_15377', 'water', 710, 'water'), ('CHEBI_15377', 'water', 743, 'water'), ('GO_0007631', 'feeding behavior', 749, 'consumption'), ('CHEBI_24870', 'ion', 785, 'iAs'), ('CHEBI_15377', 'water', 882, 'water'), ('GO_0007565', 'female pregnancy', 930, 'gestational'), ('GO_0007565', 'female pregnancy', 1003, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1028, 'prenatal')]
PMC4216381	10/2014	S90-PMC4216381	['caption (table-wrap): table 4\n\ncovariate-adjusted odds ratios for Spontaneous Pregnancy Loss in association with continuous ias exposure, by cigarette smoking (n\u2009=\u2009300)product-term enteredrisk/protector factor and ias exposurecigarette smokingaprenatal Vitamin useborc95% ciorc95% ciaverage ias (μg/l)d× risk/protector factorno0.0\xa0μg/l ias1.00reference1.00reference10.0\xa0μg/l ias0.700.44, 1.091.120.72, 1.72yes0.0\xa0μg/l ias0.970.51, 1.830.500.27, 0.9010.0\xa0μg/l ias1.750.75, 4.100.300.13, 0.67p-value for interaction0.0570.159peak ias (μg/l)e× risk/protector factorno0.0\xa0μg/l ias1.00reference1.00reference10.0\xa0μg/l ias0.730.52, 1.041.070.71, 1.63yes0.0\xa0μg/l ias0.970.51, 1.820.470.26, 0.8610.0\xa0μg/l ias1.690.76, 3.740.350.18, 0.70p-value for interaction0.0530.298daily ias (μg/day)f× risk/protector factorno0.0\xa0μg/day ias1.00reference1.00reference10.0\xa0μg/day ias0.780.58, 1.061.040.80, 1.34yes0.0\xa0μg/day ias0.940.49, 1.780.540.30, 0.9810.0\xa0μg/day ias1.410.73, 2.740.310.15, 0.63p-value for interaction0.0480.085\nan=2 influential observations excluded;\nbn=4 influential observations excluded;\nclogistic regression models incorporating continuous exposure expressed as a 10 units increase, conditioned on Gestational age (weeks), and including product-term, adjusted for maternal age (years), cigarette smoking during Pregnancy (average daily cigarettes), education (<high school, high school, university) and Prenatal vitamin use (no/yes);dmean ias level measured in up to two residential drinking Water sources;ethe highest ias level measured in up to two residential drinking Water sources;fproduct of ‘daily Water Consumption’ multiplied by ‘average ias.’\nias, inorganic Arsenic; ci, confidence interval; or, odds ratio.']	N/A	N/A	[('GO_0030474', 'spindle pole body duplication', 66, 'spontaneous'), ('GO_0006508', 'proteolysis', 78, 'pregnancy loss'), ('CHEBI_33229', 'vitamin (role)', 253, 'vitamin'), ('GO_0007565', 'female pregnancy', 1200, 'gestational'), ('GO_0007565', 'female pregnancy', 1313, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1405, 'prenatal'), ('CHEBI_15377', 'water', 1494, 'water'), ('CHEBI_15377', 'water', 1574, 'water'), ('CHEBI_15377', 'water', 1607, 'water'), ('GO_0007631', 'feeding behavior', 1613, 'consumption'), ('CHEBI_27563', 'arsenic atom', 1670, 'arsenic')]
PMC4314242	10/2014	S15-PMC4314242	['maternal Arsenic exposure, Arsenic Methylation efficiency, and Birth outcomes in the biomarkers of exposure to arsenic (bear) Pregnancy cohort in mexico.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 9, 'arsenic'), ('CHEBI_27563', 'arsenic atom', 27, 'arsenic'), ('GO_0019882', 'antigen processing and presentation', 27, 'arsenic methylation'), ('GO_0007567', 'parturition', 63, 'birth'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC4314242	10/2014	S81-PMC4314242	['detection of Arsenic in drinking Water and Urine .']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 13, 'arsenic'), ('CHEBI_15377', 'water', 33, 'water'), ('UBERON_0001088', 'urine', 43, 'urine')]
PMC4392553	3/2015	S163-PMC4392553	['in Rats exposed to Arsenic, large amounts of Gsh appeared in the Bile simultaneously with Biliary Excretion of Arsenic.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_27563', 'arsenic atom', 19, 'arsenic'), ('CHEBI_16856', 'glutathione', 45, 'GSH'), ('UBERON_0001970', 'bile', 65, 'bile'), ('UBERON_0002294', 'biliary system', 90, 'biliary'), ('GO_0007588', 'excretion', 98, 'excretion'), ('CHEBI_27563', 'arsenic atom', 111, 'arsenic')]
PMC4733817	3/2016	S23-PMC4733817	['the cohort was recruited in villages where dch has actively engaged in Arsenic-awareness campaigns and safe Water options were available.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 71, 'arsenic'), ('CHEBI_15377', 'water', 108, 'water')]
PMC4733817	3/2016	S24-PMC4733817	['all participants were able to request a technician to test their Water for Arsenic using a field test kit and were given the results immediately.']	N/A	N/A	[('CHEBI_15377', 'water', 65, 'water'), ('CHEBI_27563', 'arsenic atom', 75, 'arsenic')]
PMC4733817	3/2016	S25-PMC4733817	['in addition, all participants were informed if their Water samples contained Arsenic above the bangladesh standard after analysis by inductively coupled Plasma mass spectrometry.']	N/A	N/A	[('CHEBI_15377', 'water', 53, 'water'), ('CHEBI_27563', 'arsenic atom', 77, 'arsenic'), ('UBERON_0001969', 'blood plasma', 153, 'plasma')]
PMC4733817	3/2016	S30-PMC4733817	['exposure assessment\nArsenic was measured in maternal drinking Water samples (n = 1,140) at the time of enrollment and has been described previously.22in brief, Nitric Acid-preserved Water samples were analyzed for total Arsenic concentrations by inductively coupled Plasma mass spectrometry following us epa method 200.8 (environmental laboratory services, north syracuse, ny).']	N/A	N/A	[('CHEBI_85195', '9,10-epoxyoctadecanoate', 20, 'Arsenic'), ('CHEBI_15377', 'water', 62, 'water'), ('CHEBI_48107', 'nitric acid', 160, 'nitric acid'), ('CHEBI_15377', 'water', 182, 'water'), ('CHEBI_27563', 'arsenic atom', 220, 'arsenic'), ('UBERON_0001969', 'blood plasma', 266, 'plasma')]
PMC4733817	3/2016	S34-PMC4733817	['Digested samples were diluted with milli-q Water and analyzed for total Arsenic using an inductively coupled Plasma mass spectrometer (perkin-elmer model drc-ii 6100, norwalk, ct).']	N/A	N/A	[('GO_0007586', 'digestion', 0, 'Digested'), ('CHEBI_15377', 'water', 43, 'water'), ('CHEBI_27563', 'arsenic atom', 72, 'arsenic'), ('UBERON_0001969', 'blood plasma', 109, 'plasma')]
PMC4733817	3/2016	S35-PMC4733817	['the reported Arsenic concentrations were blank-corrected and then further corrected for systemic error by normalizing the sample concentrations using the Arsenic concentration of the batch-specific certified Human Hair reference material (crm Hair; shanghai institute of Nuclear research, academia sinica, china).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 13, 'arsenic'), ('CHEBI_27563', 'arsenic atom', 154, 'arsenic'), ('NCBITaxon_9606', 'Homo sapiens', 208, 'human'), ('UBERON_0001037', 'strand of hair', 214, 'hair'), ('UBERON_0001037', 'strand of hair', 243, 'Hair'), ('GO_0005634', 'nucleus', 271, 'Nuclear')]
PMC4733817	3/2016	S36-PMC4733817	['of the 641 Toenail samples with Arsenic measurements available, samples were excluded if the mass was ≤5 mg (n = 3) and/or if the relative standard deviation ≥25% (n = 8).']	N/A	N/A	[('UBERON_0009567', 'nail of pedal digit', 11, 'toenail'), ('CHEBI_27563', 'arsenic atom', 32, 'arsenic')]
PMC4733817	3/2016	S53-PMC4733817	['multivariate linear regression models were used to evaluate the association between ln Arsenic and Birth weight adjusting for other covariates (e.g., infant sex, maternal education, secondhand tobacco smoke exposure, entry bmi, and maternal age).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 87, 'arsenic'), ('GO_0007567', 'parturition', 99, 'birth')]
PMC4733817	3/2016	S77-PMC4733817	['the median Toenail Arsenic concentration was of 1.46 μg/g (interquartile range: 0.76, 3.73 μg/g).']	N/A	N/A	[('UBERON_0009567', 'nail of pedal digit', 11, 'toenail'), ('CHEBI_27563', 'arsenic atom', 19, 'arsenic')]
PMC4733817	3/2016	S98-PMC4733817	['specifically, Arsenic exposure directly reduced Gestational age ( βwater= −0.23 weeks, 95% ci: −0.28, −0.17; βtoe= −0.26 weeks, 95% ci: −0.40, −0.13) and directly reduced maternal weight gain during Pregnancy ( βwater= −0.009 kg/week, 95% ci: −0.01, −0.006; βtoe= −0.009 kg, 95% ci: −0.01, −0.0002).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 14, 'arsenic'), ('GO_0007565', 'female pregnancy', 48, 'gestational'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC4733817	3/2016	S116-PMC4733817	['specifically, we observed that for every doubling in Arsenic exposure measured in maternal drinking Water or maternal Toenails, Birth weight decreased by an average of 19 or 15 g, respectively.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 53, 'arsenic'), ('CHEBI_15377', 'water', 100, 'water'), ('UBERON_0009567', 'nail of pedal digit', 118, 'toenails'), ('GO_0007567', 'parturition', 128, 'birth')]
PMC4733817	3/2016	S141-PMC4733817	['Toenail samples were randomly selected by the laboratory for analysis and laboratory technicians were blinded to the concentration of Arsenic in the participant’s drinking Water.']	N/A	N/A	[('UBERON_0009567', 'nail of pedal digit', 0, 'Toenail'), ('CHEBI_27563', 'arsenic atom', 134, 'arsenic'), ('CHEBI_15377', 'water', 172, 'water')]
PMC4915063	6/2016	S168-PMC4915063	['the Gsto1 Gene, which encodes an Arsenic Detoxification enzyme, Glutathione S-Transferase Omega 1, is the only Gene in this list to have a prior association with fetal growth restriction [18].']	N/A	N/A	[('PR_000008294', 'glutathione S-transferase A1', 4, 'GSTO1'), ('SO_0000704', 'gene', 10, 'gene'), ('CHEBI_27563', 'arsenic atom', 33, 'arsenic'), ('GO_0051866', 'general adaptation syndrome', 33, 'arsenic detoxification'), ('CHEBI_16856', 'glutathione', 64, 'glutathione'), ('PR_000027594', 'histone H3', 64, 'glutathione S-transferase omega 1'), ('SO_0000704', 'gene', 111, 'gene')]
PMC4977046	3/2016	S2-PMC4977046	['methods:\namong 706 mother–infant pairs exposed to low levels of Arsenic through drinking Water and diet, we assessed in utero Arsenic exposure using maternal second-trimester Urinary Arsenic, maternal Prepregnancy weight through self-report, and Birth outcomes from medical records.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 64, 'arsenic'), ('CHEBI_15377', 'water', 89, 'water'), ('CHEBI_27563', 'arsenic atom', 126, 'arsenic'), ('UBERON_0001088', 'urine', 175, 'urinary'), ('CHEBI_27563', 'arsenic atom', 183, 'arsenic'), ('GO_0007565', 'female pregnancy', 201, 'prepregnancy'), ('GO_0007567', 'parturition', 246, 'birth')]
PMC4977046	3/2016	S3-PMC4977046	['results:\nmedian (interquartile range) of total Urinary Arsenic [tas; inorganic Arsenic (ias) + Monomethylarsonic Acid (Mma) + dimethylarsinic Acid (Dma)] was 3.4 μg/l (1.7–6.0).']	N/A	N/A	[('UBERON_0001088', 'urine', 47, 'urinary'), ('CHEBI_27563', 'arsenic atom', 55, 'arsenic'), ('CHEBI_27563', 'arsenic atom', 79, 'arsenic'), ('CHEBI_25418', 'morphinane alkaloid', 95, 'monomethylarsonic acid'), ('CHEBI_34840', 'methyl methacrylate', 119, 'MMA'), ('CHEBI_37527', 'acid', 142, 'acid'), ('CHEBI_17874', 'dihydrozeatin', 148, 'DMA')]
PMC4977046	3/2016	S70-PMC4977046	['when comparing women who were included in the analysis with the entire population-based cohort, there were no significant differences related to baseline characteristics, Arsenic exposures, or Birth outcomes (data not shown).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 171, 'arsenic'), ('GO_0007567', 'parturition', 193, 'birth')]
PMC4977046	3/2016	S79-PMC4977046	['2011), we collected and analyzed maternal second-trimester Urinary Arsenic.']	N/A	N/A	[('UBERON_0001088', 'urine', 59, 'urinary'), ('CHEBI_27563', 'arsenic atom', 67, 'arsenic')]
PMC4977046	3/2016	S82-PMC4977046	['the limits of detection (lods) ranged from 0.01 to 0.39 μg/l for the individual Arsenic species across the analysis batches.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 80, 'arsenic')]
PMC4977046	3/2016	S87-PMC4977046	['Inorganic Arsenic, Mmav, dmav, and tas concentrations were right-skewed, so values were natural log (ln)–transformed for analysis.']	N/A	N/A	[('CHEBI_5939', 'Interferon gamma-1b', 0, 'Inorganic'), ('CHEBI_27563', 'arsenic atom', 10, 'arsenic'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 19, 'MMAV')]
PMC4977046	3/2016	S93-PMC4977046	['in addition to providing Urine samples, women also provided drinking-Water samples that were analyzed for Arsenic as previously described (gilbert-diamond et al.']	N/A	N/A	[('UBERON_0001088', 'urine', 25, 'urine'), ('CHEBI_15377', 'water', 69, 'water'), ('CHEBI_27563', 'arsenic atom', 106, 'arsenic')]
PMC4977046	3/2016	S99-PMC4977046	['1994;francesconi 2010) are also known sources of Arsenic exposure in the united states, women also reported their rice and seafood intake for the 3 days before the Urine sample collection on a brief questionnaire.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 49, 'arsenic'), ('UBERON_0001088', 'urine', 164, 'urine')]
PMC4977046	3/2016	S116-PMC4977046	['baseline characteristics, maternal Urinary Arsenic concentrations, infant Gestational age, and infant Birth size measures were summarized overall and compared by maternal Prepregnancy weight status using chi-square test for categorical measures, t -tests for normally distributed continuous measures, and wilcoxon rank-sum tests for non-normally distributed continuous measures.']	N/A	N/A	[('UBERON_0001088', 'urine', 35, 'urinary'), ('CHEBI_27563', 'arsenic atom', 43, 'arsenic'), ('GO_0007565', 'female pregnancy', 74, 'gestational'), ('GO_0007567', 'parturition', 102, 'birth'), ('GO_0007565', 'female pregnancy', 171, 'prepregnancy')]
PMC4977046	3/2016	S117-PMC4977046	['we assessed the linearity of each dose–response relationship between each Arsenic exposure (ln-transformed) and each outcome using generalized additive models (gams).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 74, 'arsenic')]
PMC4977046	3/2016	S132-PMC4977046	['avariableall ( n = 706)normal weight ( n = 406)overweight/obese ( n = 300) p -valuebprepregnancy bmi (kg/m2) (mean ± sd)25.3 ± 4.922.1 ± 1.629.8 ± 4.4< 0.001maternal age (years) (mean ± sd)31.1 ± 4.731.4 ± 4.730.6 ± 4.70.03education level [ n (%)]cless than 11th grade8 (1.1)3 (0.7)5 (1.7)0.01high school graduate or equivalent68 (9.7)34 (8.4)34 (11.4)junior college graduate, or some college or technical school153 (21.8)77 (19.1)76 (25.4)college graduate275 (39.1)157 (38.9)118 (39.5)postgraduate schooling199 (28.3)133 (32.9)66 (22.1)previous Pregnancies [ n (%)]d0281 (39.9)172 (42.6)109 (36.3)0.041271 (38.5)151 (37.4)120 (40.0)296 (13.6)58 (14.4)38 (12.7)≥ 356 (8.0)23 (5.7)33 (11.0)smoking status [ n (%)]never624 (88.4)357 (87.9)267 (89.0)0.58evere45 (6.4)29 (7.1)16 (5.3)current37 (5.2)20 (4.9)17 (5.7)maternal Gestational weight gain (lbs) (mean ± sd)f32.0 ± 12.133.8 ± 9.629.5 ± 14.5< 0.001maternal Gestational hyperglycemia [ n (%)]gnormal566 (83.0)332 (84.7)234 (80.7)0.37igt70 (10.3)37 (9.4)33 (11.4)gdm46 (6.7)23 (5.9)23 (7.9)1-hr Blood Glucose challenge test resultsg(mg/dl) (mean ± sd)113 ± 28112 ± 27114 ± 290.29home Water Arsenic concentration (μg/l) [median (iqr)]0.5 (0.1–2.7)0.5 (0.1–2.6)0.5 (0.1–2.8)0.94any Seafood in 2 days before Urine collection [ n (%)]112 (15.9)69 (17.0)43 (14.3)0.39any rice in 2 days before Urine collection [ n (%)]163 (23.1)102 (25.1)61 (20.3)0.16urinary Arsenic concentration (μg/l) [median (iqr)]Inorganic Arsenic (Ias)0.3 (0.1–0.5)0.2 (0.1–0.5)0.3 (0.1–0.5)0.49monomethylarsonic Acid (Mma)0.3 (0.1–0.5)0.3 (0.1–0.5)0.3 (0.1–0.6)0.41Dimethylarsinic Acid (Dma)2.8 (1.4–4.9)2.5 (1.3–4.8)2.9 (1.4–5.1)0.27total Arsenic (Ias + Mma + Dma)3.4 (1.7–6.0)3.3 (1.6–5.7)3.6 (1.8–6.1)0.34primary methylation index (Mma/ias)1.0 (0.5–1.8)1.0 (0.5–1.8)1.0 (0.5–1.8)0.84secondary methylation index (dma/Mma)10.4 (7.6–18.3)10.3 (7.6–17.7)10.6 (7.5–18.6)0.68infant Delivery mode [ n (%)]vaginal472 (66.9)291 (71.7)181 (60.3)< 0.01cesarean section234 (33.1)115 (28.3)119 (39.7)infant Birth outcomesgestational age (weeks) (mean ± sd)39.5 ± 1.639.6 ± 1.539.3 ± 1.70.02head circumference (cm) (mean ± sd)34.7 ± 1.734.5 ± 1.834.9 ± 1.7< 0.01birth length (cm) (mean ± sd)50.9 ± 2.750.9 ± 2.650.9 ± 2.80.92birth weight (g) (mean ± sd)3,462 ± 516.83,435 ± 488.63,499 ± 551.50.11ponderal index (kg/m3) (mean ± sd)26.3 ± 3.426.1 ± 3.326.6 ± 3.60.07birth weight status [ n (%)]hsmall for Gestational age37 (5.2)24 (5.9)13 (4.3)0.02average for Gestational age600 (85.0)353 (87.0)247 (82.3)large for Gestational age69 (9.8)29 (7.1)40 (13.3)anormal weight defined as Prepregnancy bmi 18.5–24.9 kg/m2and overweight/obese defined as Prepregnancy bmi ≥ 25 kg/m2; 25 underweight mothers (bmi < 18.5 kg/m2) excluded from analysis.bcalculated from an unpaired, 2-tailed t -test with an equal variance assumption to analyze the difference in means, a chi-square test to analyze the difference in proportions, or a wilcoxon–mann–whitney test to analyze the difference in medians by maternal weight status.ceducation data missing for 3 participants.dparity data missing for 2 participants.eparticipants who reported ever smoking but did not report smoking during Pregnancy or had missing data for smoking during Pregnancy were classified as ever smokers.fdata for Gestational weight gain available for a subset of 639 women.gmaternal hyperglycemia measured as part of usual Prenatal care.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 546, 'pregnancies'), ('GO_0007565', 'female pregnancy', 820, 'gestational'), ('GO_0007565', 'female pregnancy', 910, 'gestational'), ('UBERON_0000178', 'blood', 1046, 'blood'), ('CHEBI_17234', 'glucose', 1052, 'glucose'), ('CHEBI_15377', 'water', 1135, 'water'), ('CHEBI_27563', 'arsenic atom', 1141, 'arsenic'), ('CHEBI_34973', 'Selfotel', 1231, 'seafood'), ('UBERON_0001088', 'urine', 1256, 'urine'), ('UBERON_0001088', 'urine', 1339, 'urine'), ('CHEBI_27563', 'arsenic atom', 1405, 'arsenic'), ('CHEBI_5939', 'Interferon gamma-1b', 1448, 'Inorganic'), ('CHEBI_27563', 'arsenic atom', 1458, 'arsenic'), ('CHEBI_24870', 'ion', 1467, 'iAs'), ('CHEBI_37527', 'acid', 1532, 'acid'), ('CHEBI_34840', 'methyl methacrylate', 1538, 'MMA'), ('CHEBI_17549', '5-aminolevulinic acid', 1583, '41Dimethylarsinic acid'), ('CHEBI_17874', 'dihydrozeatin', 1607, 'DMA'), ('CHEBI_85195', '9,10-epoxyoctadecanoate', 1660, 'Arsenic'), ('CHEBI_24870', 'ion', 1669, 'iAs'), ('CHEBI_34840', 'methyl methacrylate', 1675, 'MMA'), ('CHEBI_17874', 'dihydrozeatin', 1681, 'DMA'), ('CHEBI_34840', 'methyl methacrylate', 1755, 'MMA'), ('CHEBI_34840', 'methyl methacrylate', 1839, 'MMA'), ('GO_0007567', 'parturition', 1899, 'delivery'), ('GO_0007567', 'parturition', 2017, 'birth'), ('GO_0007565', 'female pregnancy', 2412, 'gestational'), ('GO_0007565', 'female pregnancy', 2467, 'gestational'), ('GO_0007565', 'female pregnancy', 2522, 'gestational'), ('GO_0007565', 'female pregnancy', 2588, 'prepregnancy'), ('GO_0007565', 'female pregnancy', 2652, 'prepregnancy'), ('GO_0007565', 'female pregnancy', 3175, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3224, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3276, 'gestational'), ('GO_0007565', 'female pregnancy', 3386, 'prenatal')]
PMC4977046	3/2016	S151-PMC4977046	['home Water Arsenic concentrations and any Intake of seafood or rice did not differ significantly by Prepregnancy weight status.']	N/A	N/A	[('CHEBI_15377', 'water', 5, 'water'), ('CHEBI_27563', 'arsenic atom', 11, 'arsenic'), ('GO_0007631', 'feeding behavior', 42, 'intake'), ('GO_0007565', 'female pregnancy', 100, 'prepregnancy')]
PMC4977046	3/2016	S167-PMC4977046	['caption (table-wrap): table 2\n\nadjusted parameter estimates (95% confidence interval) for the change in Birth outcomes with each unit increase in natural log–transformed maternal 2nd Trimester Urinary Arsenic for all participants and by maternal Prepregnancy weight status ( n \xa0=\xa0706).']	N/A	N/A	[('GO_0007567', 'parturition', 104, 'birth'), ('UBERON_0002371', 'bone marrow', 183, 'trimester'), ('UBERON_0001088', 'urine', 193, 'urinary'), ('CHEBI_27563', 'arsenic atom', 201, 'arsenic'), ('GO_0007565', 'female pregnancy', 246, 'prepregnancy')]
PMC4977046	3/2016	S168-PMC4977046	['a,boutcome/maternal Urinary Arsenic variableoverall ( n = 706)normal weight ( n = 406)overweight/obese ( n = 300) p for interactioncgestational age (weeks)dln(ias)0.04 (–0.06, 0.15)0.10 (–0.03, 0.23)–0.04 (–0.20, 0.12)0.18ln(Mma)0.05 (–0.04, 0.14)0.08 (–0.03, 0.20)0.00 (–0.13, 0.14)0.38ln(dma)0.09 (–0.03, 0.21)0.11 (–0.05, 0.27)0.07 (–0.11, 0.26)0.78ln(tas)0.10 (–0.03, 0.22)0.12 (–0.05, 0.28)0.07 (–0.11, 0.26)0.74head circumference (cm)eln(Ias)–0.08 (–0.19, 0.02)–0.12 (–0.26, 0.02)–0.04 (–0.21, 0.13)0.51ln(Mma)–0.10 (–0.19, –0.01)*–0.08 (–0.19, 0.04)–0.14 (–0.28, 0.00)*0.49ln(dma)–0.12 (–0.25, 0.00)–0.13 (–0.29, 0.04)–0.11 (–0.30, 0.08)0.90ln(tas)–0.14 (–0.27, –0.01)*–0.15 (–0.32, 0.02)–0.12 (–0.31, 0.07)0.83birth length (cm)Eln(ias)0.06 (–0.10, 0.22)0.01 (–0.20, 0.22)0.13 (–0.12, 0.39)0.46ln(Mma)0.10 (–0.04, 0.24)0.02 (–0.16, 0.20)0.21 (0.00, 0.43)0.18ln(dma)0.22 (0.03, 0.41)*0.09 (–0.16, 0.35)0.38 (0.09, 0.67)*0.14ln(tas)0.21 (0.01, 0.40)*0.07 (–0.19, 0.33)0.37 (0.08, 0.67)*0.12birth weight (g)eln(ias)–9.7 (–38.4, 19.0)–0.5 (–37.9, 37.0)–22.9 (–67.6, 21.8)0.45ln(Mma)3.9 (–20.5, 28.3)19.4 (–12.4, 51.3)–18.0 (–55.8, 19.8)0.14ln(dma)4.1 (–29.5, 37.8)24.0 (–20.5, 68.4)–21.9 (–72.8, 29.0)0.18ln(tas)–1.3 (–35.8, 33.2)15.8 (–30.1, 61.8)–23.1 (–74.9, 28.7)0.27ponderal index (kg/m3)Eln(Ias)–0.17 (–0.39, 0.05)–0.01 (–0.30, 0.28)–0.40 (–0.75, –0.06)*0.08ln(Mma)–0.13 (–0.32, 0.06)0.11 (–0.13, 0.35)–0.47 (–0.76, –0.19)*< 0.01ln(dma)–0.32 (–0.58, –0.06)*0.04 (–0.30, 0.38)–0.79 (–1.18, –0.40)**< 0.01ln(tas)–0.34 (–0.60, –0.07)*0.02 (–0.33, 0.37)–0.79 (–1.18, –0.40)**< 0.01anormal weight defined as Prepregnancy bmi 18.5–24.9 kg/m2and overweight/obese defined as Prepregnancy bmi ≥ 25 kg/m2; 25 underweight mothers (bmi < 18.5 kg/m2) excluded from analysis.bresults from a series of regression models fitting each Birth outcome on each Arsenic exposure measure [natural log–transformed inorganic Arsenic (ias), Monomethylarsonic Acid (Mma), dimethylarsinic Acid (Dma), total Arsenic (ias + Mma + Dma) (tas)]; models are adjusted as noted.cp -value from a two-sided wald’s t -test testing the significance of a multiplicative term of maternal Prepregnancy weight status (categorical) and each Arsenic exposure in the regression model.dmodel adjusted for maternal age (continuous), education level (ordinal with the five categories listed in table 1 assigned values of 1–5, respectively), parity (continuous), and infant sex; models for overall sample additionally adjusted for maternal Prepregnancy weight status (categorical).emodel adjusted for variables described in footnote d as well as Gestational age (continuous).']	N/A	N/A	[('UBERON_0001088', 'urine', 20, 'urinary'), ('CHEBI_27563', 'arsenic atom', 28, 'arsenic'), ('CHEBI_34840', 'methyl methacrylate', 225, 'MMA'), ('UBERON_0001273', 'ilium', 444, 'iAs'), ('CHEBI_34840', 'methyl methacrylate', 512, 'MMA'), ('UBERON_2001052', 'primordial hindbrain channel', 735, 'eLn'), ('CHEBI_34840', 'methyl methacrylate', 804, 'MMA'), ('CHEBI_34840', 'methyl methacrylate', 1081, 'MMA'), ('UBERON_2001052', 'primordial hindbrain channel', 1296, 'eLn'), ('UBERON_0001273', 'ilium', 1300, 'iAs'), ('CHEBI_34840', 'methyl methacrylate', 1370, 'MMA'), ('GO_0007565', 'female pregnancy', 1612, 'prepregnancy'), ('GO_0007565', 'female pregnancy', 1676, 'prepregnancy'), ('GO_0007567', 'parturition', 1827, 'birth'), ('CHEBI_27563', 'arsenic atom', 1849, 'arsenic'), ('CHEBI_27563', 'arsenic atom', 1909, 'arsenic'), ('CHEBI_25418', 'morphinane alkaloid', 1924, 'monomethylarsonic acid'), ('CHEBI_34840', 'methyl methacrylate', 1948, 'MMA'), ('CHEBI_37527', 'acid', 1970, 'acid'), ('CHEBI_17874', 'dihydrozeatin', 1976, 'DMA'), ('CHEBI_27563', 'arsenic atom', 1988, 'arsenic'), ('CHEBI_34840', 'methyl methacrylate', 2003, 'MMA'), ('CHEBI_17874', 'dihydrozeatin', 2009, 'DMA'), ('GO_0007565', 'female pregnancy', 2155, 'prepregnancy'), ('CHEBI_27563', 'arsenic atom', 2205, 'arsenic'), ('GO_0007565', 'female pregnancy', 2498, 'prepregnancy'), ('GO_0007565', 'female pregnancy', 2604, 'gestational')]
PMC4977046	3/2016	S179-PMC4977046	['maternal Urinary Arsenic was not significantly associated with Gestational age, absolute Birth weight (table 2), or Birth weight percentiles (see table s2).']	N/A	N/A	[('UBERON_0001088', 'urine', 9, 'urinary'), ('CHEBI_27563', 'arsenic atom', 17, 'arsenic'), ('GO_0007565', 'female pregnancy', 63, 'gestational'), ('GO_0007567', 'parturition', 89, 'birth'), ('GO_0007567', 'parturition', 116, 'birth')]
PMC4977046	3/2016	S188-PMC4977046	['caption (table-wrap): table 3\n\nadjusted parameter estimates (95% ci) for the change in Birth outcomes with each unit increase in natural log–transformed maternal 2nd-Trimester Urinary Arsenic by maternal Prepregnancy weight status a and infant sex strata.']	N/A	N/A	[('GO_0007567', 'parturition', 87, 'birth'), ('GO_0009294', 'DNA mediated transformation', 166, 'trimester'), ('UBERON_0001088', 'urine', 176, 'urinary'), ('CHEBI_27563', 'arsenic atom', 184, 'arsenic'), ('GO_0007565', 'female pregnancy', 204, 'prepregnancy')]
PMC4977046	3/2016	S216-PMC4977046	['a study of 299 mother–child pairs from a non–Arsenic-endemic region of taiwan (chou et al.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 45, 'arsenic')]
PMC4977046	3/2016	S248-PMC4977046	['(2009)had a median concentration of 95 μg/l of total Urinary Arsenic compared with our median of 3.4 μg/l.']	N/A	N/A	[('UBERON_0001088', 'urine', 53, 'urinary'), ('CHEBI_27563', 'arsenic atom', 61, 'arsenic')]
PMC4977047	2/2016	S3-PMC4977047	['Whole Blood Arsenic, lead, and manganese were measured using inductively coupled Plasma mass spectrometry.']	N/A	N/A	[('UBERON_0004043', 'semicircular canal ampulla', 0, 'Whole'), ('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_27563', 'arsenic atom', 12, 'arsenic'), ('UBERON_0001969', 'blood plasma', 81, 'plasma')]
PMC4977047	2/2016	S5-PMC4977047	['results:\nmedian (25th–75th percentile) maternal and Umbilical Cord Blood metal concentrations, respectively, were as follows: Arsenic, 1.4 (1.0–2.3) and 2.4 (1.8–3.3) μg/l; lead, 0.6 (0.4–0.9) and 0.4 (0.3–0.6) μg/dl; Manganese, 22.7 (18.8–29.3) and 41.7 (32.2–50.4) μg/l.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 52, 'umbilical cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_27563', 'arsenic atom', 126, 'arsenic'), ('CHEBI_33351', 'seaborgium atom', 218, 'manganese')]
PMC4977047	2/2016	S13-PMC4977047	['Prenatal Arsenic exposure and Birth outcomes among a population residing near a mining-related superfund site.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27563', 'arsenic atom', 9, 'arsenic'), ('GO_0007567', 'parturition', 30, 'birth')]
PMC4977047	2/2016	S18-PMC4977047	['Metals, including lead (Pb), manganese (Mn), and inorganic Arsenic (as), readily cross the Placenta (concha et al.']	N/A	N/A	[('CHEBI_44075', 'methyl L-leucinate', 0, 'Metals'), ('CHEBI_37983', 'sulfur-35 atom', 24, 'Pb'), ('CHEBI_25614', 'nylons', 40, 'Mn'), ('CHEBI_27563', 'arsenic atom', 59, 'arsenic'), ('UBERON_0001987', 'placenta', 91, 'placenta')]
PMC4977047	2/2016	S73-PMC4977047	['exposure assessment\nMaternal Blood and Umbilical Cord Blood samples were collected at Delivery (± 12 hr) and analyzed for total Arsenic concentration at the trace metals laboratory at hsph (boston, ma).']	N/A	N/A	[('UBERON_0000976', 'humerus', 20, 'Maternal'), ('UBERON_0000178', 'blood', 29, 'blood'), ('UBERON_0002331', 'umbilical cord', 39, 'umbilical cord'), ('UBERON_0000178', 'blood', 54, 'blood'), ('GO_0007567', 'parturition', 86, 'delivery'), ('CHEBI_27563', 'arsenic atom', 128, 'arsenic')]
PMC4977047	2/2016	S77-PMC4977047	['total Arsenic, lead, and manganese concentrations were measured with a dynamic reaction cell/inductively coupled Plasma mass spectrometer (drc/icp-ms; elan 6100; perkinelmer, norwalk, ct) using previously published methods and quality control procedures (chen et al.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 6, 'arsenic'), ('UBERON_0001969', 'blood plasma', 113, 'plasma')]
PMC4977047	2/2016	S81-PMC4977047	['the limit of detection (lod) was 0.02 μg/dl for Blood Arsenic, lead, and manganese.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('CHEBI_27563', 'arsenic atom', 54, 'arsenic')]
PMC4977047	2/2016	S82-PMC4977047	['two (0.3%) Arsenic and three (0.5%) lead measurements in Cord Blood were below the lod, for which we assigned a value of half the lod.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 11, 'arsenic'), ('UBERON_0009472', 'axilla', 57, 'cord blood')]
PMC4977047	2/2016	S91-PMC4977047	['associations between Arsenic and four Birth outcomes were estimated: Birth weight (g), Gestational age (weeks), Head circumference (cm), and Birth weight for Gestational age ( z -score).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 21, 'arsenic'), ('GO_0007567', 'parturition', 38, 'birth'), ('GO_0007567', 'parturition', 69, 'birth'), ('GO_0007565', 'female pregnancy', 87, 'gestational'), ('UBERON_0000033', 'head', 112, 'head'), ('GO_0007567', 'parturition', 141, 'birth'), ('GO_0007565', 'female pregnancy', 158, 'gestational')]
PMC4977047	2/2016	S122-PMC4977047	['2013), by weighting models with the inverse of the Arsenic measurement error (exposure) variance of the five laboratory replicates per sample (cochran and carroll 1953).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 51, 'arsenic')]
PMC4977047	2/2016	S129-PMC4977047	['of 622 mother–infant pairs, data were not available for 4 (0.6%) maternal and 13 (2%) Cord Blood Arsenic measurements, 3 (0.5%) Cord Blood lead and Manganese measurements, and 24 (3.9%) Head circumference measurements at Birth.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 86, 'cord'), ('UBERON_0000178', 'blood', 91, 'blood'), ('CHEBI_27563', 'arsenic atom', 97, 'arsenic'), ('UBERON_0002240', 'spinal cord', 128, 'cord'), ('UBERON_0000178', 'blood', 133, 'blood'), ('CHEBI_33351', 'seaborgium atom', 148, 'manganese'), ('UBERON_0000033', 'head', 186, 'head'), ('GO_0007567', 'parturition', 221, 'birth')]
PMC4977047	2/2016	S133-PMC4977047	['median (25th–75th percentile) maternal and Umbilical Cord Blood metal concentrations, respectively, were, for Arsenic, 1.4 (0.97–2.3) and 2.4 (1.8–3.3) μg/l; lead, 0.60 (0.41–0.88) and 0.43 (0.28–0.62) μg/dl; Manganese, 22.7 (18.8–29.3) and 41.7 (32.2–50.4) μg/l.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 43, 'umbilical cord'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_27563', 'arsenic atom', 110, 'arsenic'), ('CHEBI_33351', 'seaborgium atom', 209, 'manganese')]
PMC4977047	2/2016	S143-PMC4977047	['primiparous mothers had 12% lower Arsenic than multiparous women (β = –0.13; 95% ci: –0.24, –0.03).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 34, 'arsenic')]
PMC4977047	2/2016	S144-PMC4977047	['compared to white mothers, native american mothers had 14% higher (β = 0.13; 95% ci: 0.01, 0.26) and other ethnicities had 17% lower (β = –0.19; 95% ci: –0.38, –0.01) Arsenic levels.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 167, 'arsenic')]
PMC4977047	2/2016	S148-PMC4977047	['adjusted effect estimates and 95% cis for all Birth outcomes across quartiles of maternal Blood Arsenic are presented infigure 1.']	N/A	N/A	[('GO_0007567', 'parturition', 46, 'birth'), ('UBERON_0000178', 'blood', 90, 'blood'), ('CHEBI_27563', 'arsenic atom', 96, 'arsenic')]
PMC4977047	2/2016	S151-PMC4977047	['caption (fig): figure 1\n\neffect estimates and 95% confidence intervals for quartiles of maternal Blood Arsenic with Birth weight (bw), Gestational age (ga), weight for Gestational age (bw for ga), and Head circumference (hc).']	N/A	N/A	[('UBERON_0000178', 'blood', 97, 'blood'), ('CHEBI_27563', 'arsenic atom', 103, 'arsenic'), ('GO_0007567', 'parturition', 116, 'birth'), ('GO_0007565', 'female pregnancy', 135, 'gestational'), ('GO_0007565', 'female pregnancy', 168, 'gestational'), ('UBERON_0000033', 'head', 201, 'head')]
PMC4977047	2/2016	S157-PMC4977047	['there was no difference in fit between models with Cord Arsenic parameterized as quartiles and as continuous loge-transformed concentrations (likelihood ratio tests: p> 0.05 for all Birth outcomes) and no significant association between continuous Cord Arsenic and Birth outcomes (see table s1).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 51, 'cord'), ('CHEBI_27563', 'arsenic atom', 56, 'arsenic'), ('GO_0007567', 'parturition', 182, 'birth'), ('UBERON_0002240', 'spinal cord', 248, 'cord'), ('CHEBI_27563', 'arsenic atom', 253, 'arsenic'), ('GO_0007567', 'parturition', 265, 'birth')]
PMC4977047	2/2016	S158-PMC4977047	['caption (fig): figure 2\n\neffect estimates and 95% confidence intervals for quartiles of Cord Blood Arsenic with Birth weight (bw), Gestational age (ga), weight for Gestational age (bw for ga), and Head circumference (hc).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_27563', 'arsenic atom', 99, 'arsenic'), ('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007565', 'female pregnancy', 131, 'gestational'), ('GO_0007565', 'female pregnancy', 164, 'gestational'), ('UBERON_0000033', 'head', 197, 'head')]
PMC4977047	2/2016	S162-PMC4977047	['no significant interactions were observed between maternal or Cord Blood Arsenic with lead or manganese (see table s2).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_27563', 'arsenic atom', 73, 'arsenic')]
PMC4977047	2/2016	S163-PMC4977047	['when we included a cross-product term between Arsenic and sex, the interaction terms were not significant for maternal or Cord Blood Arsenic with any Birth outcomes (e.g., Birth weight: maternal as × sex, p = 0.6; data not shown).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 46, 'arsenic'), ('UBERON_0002240', 'spinal cord', 122, 'cord'), ('UBERON_0000178', 'blood', 127, 'blood'), ('CHEBI_27563', 'arsenic atom', 133, 'arsenic'), ('GO_0007567', 'parturition', 150, 'birth'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC4977047	2/2016	S180-PMC4977047	['discussion\nin this u.s. population, Arsenic concentrations in maternal and Cord Blood were lower relative to studies conducted in asia and south america (ahmed et al.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 36, 'arsenic'), ('UBERON_0002240', 'spinal cord', 75, 'cord'), ('UBERON_0000178', 'blood', 80, 'blood')]
PMC5028238	10/2016	S148-PMC5028238	['two inorganic compounds increase Dhcr7 Expression, whereas three Toxins (including a Metabolite of Arsenic) decrease Dhcr7 Expression and one toxin decreases protein activity.']	N/A	N/A	[('PR_000006474', 'ATP-dependent RNA helicase A', 33, 'DHCR7'), ('GO_0010467', 'gene expression', 39, 'expression'), ('CHEBI_27026', 'toxin', 65, 'toxins'), ('CHEBI_39382', 'flufenoxuron', 85, 'metabolite'), ('CHEBI_27563', 'arsenic atom', 99, 'arsenic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 117, 'DHCR7'), ('GO_0010467', 'gene expression', 123, 'expression')]
PMC5030620	9/2016	S115-PMC5030620	['poor nutrition (Reduced Folate), Detoxification Of Arsenic and Consumption Of Glutathione during the Detoxification Of Reactive Oxygen Species can all lead to reduced levels of the dnmt co-substrate S -Adenosylmethionine (hou et\xa0al.2012; ruiz-hernandez et\xa0al.2015).']	N/A	N/A	[('CHEBI_46665', 'riebeckite', 16, 'reduced folate'), ('GO_0070983', 'dendrite guidance', 33, 'detoxification of arsenic'), ('CHEBI_27563', 'arsenic atom', 51, 'arsenic'), ('GO_0036271', 'response to methylphenidate', 63, 'consumption of glutathione'), ('CHEBI_16856', 'glutathione', 78, 'glutathione'), ('GO_0002241', 'response to parasitic plant', 101, 'detoxification of reactive oxygen species'), ('CHEBI_26523', 'reactive oxygen species', 119, 'reactive oxygen species'), ('CHEBI_52260', 'rhod-2 dye', 199, 'S'), ('CHEBI_22205', 'acetylspermine', 202, 'adenosylmethionine')]
PMC5100620	10/2016	S143-PMC5100620	['the matlab area, as well as other parts of the delta region in bangladesh, has varying levels of Arsenic contamination of drinking Water from tube wells.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 97, 'arsenic'), ('CHEBI_15377', 'water', 131, 'water')]
PMC5334760	2/2017	S50-PMC5334760	['uic was determined by the Arsenic–cerium catalytic spectrophotometry.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 26, 'arsenic')]
PMC5718612	12/2017	S7-PMC5718612	['coli as contributors to the Arsenic enriched seed functions.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 28, 'arsenic')]
PMC5718612	12/2017	S10-PMC5718612	['we then performed quantification by qpcr of two Arsenic resistant Genes (Arsb, Arsc).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 48, 'arsenic'), ('SO_0000704', 'gene', 66, 'genes'), ('PR_000004155', 'apolipoprotein E', 73, 'ArsB'), ('PR_000004155', 'apolipoprotein E', 79, 'ArsC')]
PMC5718612	12/2017	S16-PMC5718612	['one country that is heavily affected by Arsenic-contaminated drinking Water is bangladesh [2].']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 40, 'arsenic'), ('CHEBI_15377', 'water', 70, 'water')]
PMC5718612	12/2017	S26-PMC5718612	['furthermore, Arsenic in drinking Water crosses the Placenta [22] but Arsenic is not transmitted in Breast Milk [23].']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 13, 'arsenic'), ('CHEBI_15377', 'water', 33, 'water'), ('UBERON_0001987', 'placenta', 51, 'placenta'), ('CHEBI_27563', 'arsenic atom', 69, 'arsenic'), ('UBERON_0001348', 'brown adipose tissue', 99, 'breast milk')]
PMC5718612	12/2017	S31-PMC5718612	['results\nthe mean drinking Water Arsenic concentration for the high and low exposed groups was 218.8 μg/l (standard deviation, sd: 166.1 μg/l) and 1.7 μg/l (sd: 1.9 μg/l), respectively.']	N/A	N/A	[('CHEBI_15377', 'water', 26, 'water'), ('CHEBI_27563', 'arsenic atom', 32, 'arsenic')]
PMC5718612	12/2017	S34-PMC5718612	['analysis of alpha and beta diversity of microbiota did not indicate global differences in bacterial communities between high and low Arsenic exposure groups (s1 fig).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 133, 'arsenic')]
PMC5718612	12/2017	S35-PMC5718612	['next, we compared microbial frequencies between the high and low Arsenic exposure groups.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 65, 'arsenic')]
PMC5718612	12/2017	S39-PMC5718612	['(a) relative abundance of Phyla for high Arsenic exposure samples (n = 25, orange color) and low exposure samples (n = 25, blue color).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 26, 'phyla'), ('CHEBI_27563', 'arsenic atom', 41, 'arsenic')]
PMC5718612	12/2017	S43-PMC5718612	['(b) relative abundance of three lower Taxonomic ranks of Phylum proteobacteria for high Arsenic exposure and unexposed samples.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 38, 'taxonomic'), ('NCBITaxon_33208', 'Metazoa', 57, 'phylum'), ('CHEBI_27563', 'arsenic atom', 88, 'arsenic')]
PMC5718612	12/2017	S62-PMC5718612	['(a) heatmap showing fold change of 901 different abundant seed functions between high exposure versus low exposure group and correlation coefficients (spearman) with Arsenic levels in high exposure group for 332 seed functions.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 166, 'arsenic')]
PMC5718612	12/2017	S82-PMC5718612	['coli is the Genome that contributed to the seed functions enriched among the high Arsenic exposure group.']	N/A	N/A	[('SO_0001026', 'genome', 12, 'genome'), ('CHEBI_27563', 'arsenic atom', 82, 'arsenic')]
PMC5718612	12/2017	S87-PMC5718612	['frequency of seed Genes annotated under specific seed level 2 function categories within 332 Arsenic related seed functions (black color) and all seed functions detected in the samples.']	N/A	N/A	[('SO_0000704', 'gene', 18, 'genes'), ('CHEBI_27563', 'arsenic atom', 93, 'arsenic')]
PMC5718612	12/2017	S88-PMC5718612	['the seed level function categories in the figure are significantly overrepresented or depleted in the 332 Arsenic related functions (chi-square test p value <0.05).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 106, 'arsenic')]
PMC5718612	12/2017	S91-PMC5718612	['we observed that 78% of Arsenic-enriched Genes (258 Genes) were also found in the bacteria surviving long-term Antibiotic treatment in the Mouse gut (fig 2a;s3 table).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 24, 'arsenic'), ('SO_0000704', 'gene', 41, 'genes'), ('SO_0000704', 'gene', 52, 'genes'), ('CHEBI_33282', 'antibacterial agent', 111, 'antibiotic'), ('NCBITaxon_10088', 'Mus <genus>', 139, 'mouse')]
PMC5718612	12/2017	S104-PMC5718612	['through blastn search against ncbi nucleotide database, the two Contigs (44.fastq_1_63:c75111 and 27.fastq_1_31:c431936) that harbor those two different Arsenic resistance Operons, were assigned to e .']	N/A	N/A	[('SO_0000149', 'contig', 64, 'contigs'), ('CHEBI_27563', 'arsenic atom', 153, 'arsenic'), ('SO_0000178', 'operon', 172, 'operons')]
PMC5718612	12/2017	S115-PMC5718612	['c) qpcr quantification of two Arsenic resistance Operon Genes (Arsb, Arsc) found in bangladeshi children e .']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 30, 'arsenic'), ('SO_0000178', 'operon', 49, 'operon'), ('SO_0000704', 'gene', 56, 'genes'), ('PR_000004155', 'apolipoprotein E', 63, 'ArsB'), ('PR_000004155', 'apolipoprotein E', 69, 'ArsC')]
PMC5718612	12/2017	S119-PMC5718612	['coli strain Contigs found in the bangladeshi children (from both high exposure and low exposure groups)with the Contigs in the Gut microbiome from a european cohort [34] that does not experience the same level of Arsenic exposure as bangladesh.']	N/A	N/A	[('SO_0000149', 'contig', 12, 'contigs'), ('SO_0000149', 'contig', 112, 'contigs'), ('UBERON_0001555', 'digestive tract', 127, 'gut'), ('CHEBI_27563', 'arsenic atom', 213, 'arsenic')]
PMC5718612	12/2017	S129-PMC5718612	['specifically, we observed that species within the proteobacteria phylum, enterobacteriaceae family, predominantly Arsenic resistant e .']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 114, 'arsenic')]
PMC5718612	12/2017	S130-PMC5718612	['coli , were more abundant in children who had high Arsenic exposure during the Prenatal and Perinatal Period.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 51, 'arsenic'), ('GO_0007565', 'female pregnancy', 79, 'prenatal'), ('GO_0036268', 'swimming', 92, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 92, 'perinatal period')]
PMC5718612	12/2017	S153-PMC5718612	['also, we assigned children into the two exposure categories based on the amount of Arsenic measured in their household’s drinking Water.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 83, 'arsenic'), ('CHEBI_15377', 'water', 130, 'water')]
PMC5718612	12/2017	S161-PMC5718612	['for instance, we categorized this population based on Prenatal Arsenic exposure levels and examined the microbiota in children up to 6 years later.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 54, 'prenatal'), ('CHEBI_27563', 'arsenic atom', 63, 'arsenic')]
PMC5718612	12/2017	S171-PMC5718612	['coli strains that harbor Arsenic resistance Operons and those were not detected in the Gut Microbiome of european cohort [34] that do not live in highly Arsenic contaminated regions.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 25, 'arsenic'), ('SO_0000178', 'operon', 44, 'operons'), ('UBERON_0010328', 'limb bud mesenchyme', 87, 'gut microbiome'), ('CHEBI_27563', 'arsenic atom', 153, 'arsenic')]
PMC5718612	12/2017	S174-PMC5718612	['moreover, the Arsenic resistant system (arsrbc), when working, by reducing as(v) into as(Iii) via a Cytoplasmic Arsenate reductase (Arsc) and extruding the latter from the cellular compartment by means of a Membranous as(iii) efflux pump (Arsb).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 14, 'arsenic'), ('CHEBI_16382', 'iodide', 89, 'III'), ('GO_0005737', 'cytoplasm', 100, 'cytoplasmic'), ('CHEBI_29125', 'arsenate(3-)', 112, 'arsenate'), ('PR_000004155', 'apolipoprotein E', 132, 'ArsC'), ('GO_0016020', 'membrane', 207, 'membranous'), ('PR_000004155', 'apolipoprotein E', 239, 'ArsB')]
PMC5718612	12/2017	S180-PMC5718612	['specifically, we recruited 25 children aged 4–6 years old who were exposed to high Arsenic exposure during development and in early Life and matched them on sex, location of residence, and age (within 6 months) with children who had low Arsenic exposure during development and early Life.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 83, 'arsenic'), ('UBERON_0000104', 'life cycle', 132, 'life'), ('CHEBI_27563', 'arsenic atom', 237, 'arsenic'), ('UBERON_0000104', 'life cycle', 283, 'life')]
PMC5718612	12/2017	S182-PMC5718612	['overall, the level of Arsenic in this region spans a wide range.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 22, 'arsenic')]
PMC5718612	12/2017	S184-PMC5718612	['the median Arsenic concentration in this group was 1.3 μg/l but approximately 26% of the households exceeded the bangladesh drinking Water standard of 50 μg/l.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 11, 'arsenic'), ('CHEBI_15377', 'water', 133, 'water')]
PMC5718612	12/2017	S185-PMC5718612	['in this nested study, we defined high Arsenic exposure as the household’s drinking Water well contained > 50 μg/l and low Arsenic exposure was defined as the household’s well contained <10 μg/l.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 38, 'arsenic'), ('CHEBI_15377', 'water', 83, 'water'), ('CHEBI_27563', 'arsenic atom', 122, 'arsenic')]
PMC5718612	12/2017	S209-PMC5718612	['total Arsenic was measured using inductively coupled Plasma-mass spectrometry following us epa method 200.8 (environmental laboratory services, north syracuse, new york).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 6, 'arsenic'), ('UBERON_0001969', 'blood plasma', 53, 'plasma')]
PMC5718612	12/2017	S251-PMC5718612	['Arsenic Metabolism Gene annotation of Orfs was performed by blastx search against bacmet database predicted Arsenic Metabolism protein dataset (http://bacmet.biomedicine.gu.se/download/bacmet_pre.40556.fasta).']	N/A	N/A	[('CHEBI_85195', '9,10-epoxyoctadecanoate', 0, 'Arsenic'), ('GO_0018871', '1-aminocyclopropane-1-carboxylate metabolic process', 0, 'Arsenic metabolism'), ('SO_0000704', 'gene', 19, 'gene'), ('SO_0000236', 'ORF', 38, 'ORFs'), ('CHEBI_27563', 'arsenic atom', 108, 'arsenic'), ('GO_0019566', 'arabinose metabolic process', 108, 'arsenic metabolism')]
PMC5718612	12/2017	S255-PMC5718612	['Primers for Arsenic resistance Genes were: Arsc F:5’tgccgatatggggatttccg, Arsc R:5’agcgtttacccgcttcatca(product length 275 Bp); Arsb F:5’cgcagatttctttggcctcg, Arsb R:5’aatcgcagccaatcacgttg(product length 620 Bp).']	N/A	N/A	[('SO_0000112', 'primer', 0, 'Primers'), ('CHEBI_27563', 'arsenic atom', 12, 'arsenic'), ('SO_0000704', 'gene', 31, 'genes'), ('PR_000004155', 'apolipoprotein E', 43, 'ArsC'), ('SO_0001030', 'forward', 48, 'F'), ('PR_000004155', 'apolipoprotein E', 74, 'ArsC'), ('SO_0001031', 'reverse', 79, 'R'), ('SO_0000028', 'base_pair', 123, 'bp'), ('PR_000004155', 'apolipoprotein E', 128, 'ArsB'), ('SO_0001030', 'forward', 133, 'F'), ('PR_000004155', 'apolipoprotein E', 159, 'ArsB'), ('SO_0001031', 'reverse', 164, 'R'), ('SO_0000028', 'base_pair', 208, 'bp')]
PMC5718612	12/2017	S269-PMC5718612	['chi-squared test was also used to measure the significance of overlap between Arsenic-related Genes and Genes enriched by Antibiotics treatment.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 78, 'arsenic'), ('SO_0000704', 'gene', 94, 'genes'), ('SO_0000704', 'gene', 104, 'genes'), ('CHEBI_33282', 'antibacterial agent', 122, 'antibiotics')]
PMC5718612	12/2017	S282-PMC5718612	['caption (supplementary-material): s6 fig\nAntibiotic resistance Genes by Arsenic exposure.']	N/A	N/A	[('CHEBI_33282', 'antibacterial agent', 41, 'Antibiotic'), ('SO_0000704', 'gene', 63, 'genes'), ('CHEBI_27563', 'arsenic atom', 72, 'arsenic')]
PMC5718612	12/2017	S284-PMC5718612	['caption (supplementary-material): s7 fig\nabundance of Arsenic resistance Genes in high Arsenic exposure group.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 54, 'arsenic'), ('SO_0000704', 'gene', 73, 'genes'), ('CHEBI_27563', 'arsenic atom', 87, 'arsenic')]
PMC5718612	12/2017	S292-PMC5718612	['caption (supplementary-material): s1 table\nabundance of kegg functions between high and low Arsenic exposure groups.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 92, 'arsenic')]
PMC5718612	12/2017	S294-PMC5718612	['caption (supplementary-material): s2 table\nabundance of bacterial Genes between high and low Arsenic exposure groups with differential abundance (two-tailed p <0.1).']	N/A	N/A	[('SO_0000704', 'gene', 66, 'genes'), ('CHEBI_27563', 'arsenic atom', 93, 'arsenic')]
PMC5718612	12/2017	S300-PMC5718612	['caption (supplementary-material): s5 table\nContigs that harbor Arsenic resistance Operons identified through blastn search against ncbi nucleotide database.']	N/A	N/A	[('SO_0000172', 'CAAT_signal', 43, 'Contigs'), ('CHEBI_27563', 'arsenic atom', 63, 'arsenic'), ('SO_0000178', 'operon', 82, 'operons')]
PMC5919629	4/2018	S64-PMC5919629	['data on Intake of Arsenic contaminated Water were retrospectively collected by hdss.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_27563', 'arsenic atom', 18, 'arsenic'), ('CHEBI_15377', 'water', 39, 'water')]
PMC5919629	4/2018	S66-PMC5919629	['accordingly, we categorized women as “Consumed Arsenic contaminated Water” if they used to consume Water from the red tube wells, “Consumed Arsenic free Water” if they Consumed from the green tube wells and “unknown” if they Consumed from the “not tested yet” tube wells.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 38, 'consumed'), ('CHEBI_27563', 'arsenic atom', 47, 'arsenic'), ('CHEBI_15377', 'water', 68, 'water'), ('CHEBI_15377', 'water', 99, 'water'), ('GO_0007631', 'feeding behavior', 131, 'consumed'), ('CHEBI_27563', 'arsenic atom', 140, 'arsenic'), ('CHEBI_15377', 'water', 153, 'water'), ('GO_0007631', 'feeding behavior', 168, 'consumed'), ('GO_0007631', 'feeding behavior', 225, 'consumed')]
PMC5919629	4/2018	S95-PMC5919629	['one in every six women (16.8%) used to consume Arsenic-contaminated Water.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 47, 'arsenic'), ('CHEBI_15377', 'water', 68, 'water')]
PMC5919629	4/2018	S114-PMC5919629	['aadjusted odds ratio from a multivariable model that includes: age, religion, education, economic status (wealth quintile), whether the mother’s primary source of drinking Water contains Arsenic, the season of Conception, the nutritional status including height and pre-third Trimester bmi, and parity.']	N/A	N/A	[('CHEBI_15377', 'water', 172, 'water'), ('CHEBI_27563', 'arsenic atom', 187, 'arsenic'), ('GO_0007620', 'copulation', 210, 'conception'), ('GO_0009294', 'DNA mediated transformation', 276, 'trimester')]
